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ABSTRACT 
 
 
 Neurological deficits caused by fetal exposure to ethanol remains prevalent and are 
recognized as a serious public health issue. The effects of fetal alcohol exposure are 
multifaceted and is characterized by multiple structural malformations and cognitive 
deficiencies, however the basic molecular mechanisms central to these defects are not 
thoroughly understood. A central factor in embryonic development is post-
transcriptional gene regulation. Post-transcriptional regulation governs all aspects of 
development and is an area of vulnerability that is targeted by ethanol. nELAVs RNA 
binding proteins are important post transcriptional regulators involved in RNA 
translocation and stability. Elucidating ethanol's effects as a teratogen on these regulators 
their target transcripts and binding partners will enable us to implement strategies to 
diminish several long-term effects of fetal ethanol exposure.  
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CHAPTER I  
INTRODUCTION  
 
 
Neurological deficits caused by fetal exposure to ethanol remain prevalent and 
are recognized as a serious public health issue. Fetal alcohol exposure can result in a 
multifaceted disorder that is characterized by numerous structural malformations and 
cognitive deficiencies, the basic molecular mechanisms central to these defects are not 
thoroughly understood. Gene regulation occurs both transcriptionally and post 
transcriptionally. Post-transcriptional regulation is fundamental for embryonic 
development and regulates transcript-processing mechanisms such as translocation, 
stability and translation efficiency. Because of the regulatory processes involved in 
embryonic development, post-transcriptional regulation is an area of vulnerability that is 
targeted by teratogens such as ethanol.  Two significant post-transcriptional regulators 
are the RNA binding proteins and the non-coding microRNAs. Elucidating ethanol's 
effects as a teratogen on post-transcriptional gene regulation will enable us to implement 
strategies to diminish several long-term effects of fetal alcohol exposure. This 
dissertation seeks to promote our understanding of the effects of ethanol exposure on 
post-transcriptional gene regulators at critical time points during embryonic 
development. 
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Fetal alcohol spectrum disorders 
The maternal fetal environment is critical for the development of the embryo. In-
utero exposure to varying levels of teratogens result in developmental malfunctions 
leading to neurological deficits and structural abnormalities (Fernandez et al., 2004, 
Vajda et al., 2013). Maternal alcohol consumption during pregnancy varies widely 
among individuals (May et al., 2013b) and as such the effects of alcohol exposure on the 
developing fetus can be very profound with varying degrees of severity. Fetal alcohol 
exposure results in a collection of mental and physical deficits, collectively termed Fetal 
Alcohol Spectrum Disorders (FASD) (Bertrand et al., 2005, Autti-Ramo et al., 2006). 
Prenatal alcohol exposure has long been implicated as being detrimental to the 
developing fetus (Sullivan, 2011), however, it was notably clinically characterized by 
Jones and Smith in 1973 (Jones and Smith, 1973). Specifically FASD includes 
neuropsychological deficits, craniofacial abnormalities, growth and bone deficiencies, 
cardiac anomalies and several other congenital defects (Jones and Smith, 1973, Paintner 
et al., 2012, Thanh and Jonsson, 2014). Because FASD is a complex disorder, 
characterization is complicated, however, a set of criteria for diagnosis was determined, 
and include Fetal Alcohol Syndrome (FAS), Partial Fetal Alcohol Syndrome (pFAS) 
(Moore et al., 2001, Bertrand et al., 2005), Alcohol Related Neurodevelopment Disorder 
(ARND) and Alcohol Related Birth Defects (ARBD) (Hoyme et al., 2005, May et al., 
2013a). FAS is at the severe end of the spectrum with confirmed prenatal exposure, 
along with neurological damage and dysfunction, growth abnormalities, both prenatally 
and postnatally along with 
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described by Jones and Smith (Jones and Smith, 1973). pFAS is characterized by 
confirmed fetal exposure with some evidence of the characteristic facial dysmorphology 
seen in FAS, in addition to abnormal brain morphology, cognitive deficits and other 
neurological impairments (Hoyme et al., 2005). ARND is characterized by confirmed 
maternal alcohol use during pregnancy and presentation of minimal brain structure 
impairment and minimal characteristic dysmorphologies compared to what is seen in 
FAS and pFAS, but there are deficits in executive functioning, lack of acceptable social 
behavior and other cognitive deficits (Chudley et al., 2005, May et al., 2007). ARBD is 
characterized by subtler neurodevelopmental deficiencies and minor dysmorphologies 
resulting from prenatal alcohol exposure (May et al., 2007). ARBD characterization is 
more difficult as other congenital malformations can occur that are not attributed to 
prenatal alcohol exposure (O'Leary et al., 2010, Wilkins-Haug, 1997).  
 
Impact of ethanol on fetal developmental mechanisms 
Fetal alcohol exposure results in a range of deficits with the main area of 
vulnerability being neurological, specifically affecting the fetal brain. Because FASD is 
a spectrum disorder, the severity is variable and it is theorized that the time of exposure 
during development determines the variability in severity (Coulter et al., 1993). In fetal 
brain development, neural stem and progenitor cells undergo proliferation and 
maturation between the end period of the first trimester and start of the second trimester. 
Exposure to teratogens such as alcohol at this critical developmental period is known to 
cause neurological deficits and brain dysmorphologies. However, the molecular 
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mechanisms of ethanol exposure that renders the developing brain vulnerable remains 
unknown.  In addition to gestational age of exposure, the quantity of maternal alcohol 
consumption is also of significance. When alcohol is consumed during pregnancy, there 
is evidence that the fetal amniotic fluid concentration equals that of the maternal blood 
within two hours post consumption (Nava-Ocampo et al., 2004), and also took a 
considerably longer time to be metabolized from the amniotic fluid (Nava-Ocampo et 
al., 2004).  Interestingly, this pharmacokinetic model by Nava-Ocampo et al., gives 
insight into ethanol exposure at the crucial gestational age time point for neuronal 
development around the early second trimester period. In addition, cortical neuronal 
migration in humans also begins in the second trimester period (Bielas et al., 2004). This 
second trimester is very significant in embryogenesis and brain development, as two 
critical events, neurogenesis and migration takes place during this period. This second 
trimester period represents the focus of my research as the events occurring make the 
developing fetal brain particularly vulnerable to teratogens and may be the time point 
during development that the teratogenic effects of alcohol will be greatest. Even though 
we focus on the second trimester period it must be noted that the deleterious effects of 
alcohol exposure during pregnancy occur in all three trimesters therefore there is no safe 
period or lower limit for alcohol consumption during pregnancy. Fetal alcohol exposure 
very early in embryogenesis before maternal realization of pregnancy has been shown to 
be very detrimental to the developing fetus. Magnetic Resonance Microscopy of mouse 
models of ethanol exposure shows that in early first trimester equivalency periods, 
exposure at mouse gestational day seven and eight, the beginning of gastrulation and 
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neural plate formation, ethanol administration resulted in several characteristic FAS 
features such as facial dysmorphologies and cerebral cortical heterotopias (Parnell et al., 
2009, Godin et al., 2010, Parnell et al., 2014). In the second trimester, exposure to 
alcohol affects the proliferation and maintenance of neuronal precursor cells causing 
aberrant migration of cortical neurons (Camarillo and Miranda, 2008). Synaptogenesis 
and establishment of neural circuitry occurs in the third trimester, during this period the 
brain may be more susceptible to apoptosis due to alcohol consumption (Ikonomidou et 
al., 2001). Ethanol has been shown to decrease mRNA levels of several antioxidant 
enzymes such as glutathione peroxidase and superoxide dismutase in the fetal brain but 
not the fetal liver (Drever et al., 2012), this may mean that the protection afforded by 
these antioxidants is diminished leading to oxidative damage of nucleotides or 
transcription and post transcription factors. Alcohol disrupts several genes in the 
developing brain (Drever et al., 2012, Khalid et al., 2014). Alcohol affects inhibitory 
pathways in the central nervous system (Toso et al., 2006). Alcohol affects blood flow to 
the fetal brain (Bake et al., 2012), alcohol exposure causes epigenetic reprogramming 
(Veazey et al., 2013) and alter vulnerable neural stem cell populations (Tingling et al., 
2013). As the evidence indicates, fetal alcohol exposure disrupts developmental 
programs that regulate embryonic brain development. Because ethanol's effect on the 
developing fetal brain is deleterious, this presents a formidable challenge for us to 
understand the complexities underlying teratogenicity of ethanol on the developing 
brain. In the context of neurological disorders observed in FASD, alcohol can be 
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considered to be exerting its effects on core gene regulatory factors that govern 
neurogenesis, neural migration and maturation.  
 
Neurogenesis, neuronal migration and differentiation 
Neurons communicate by forming extensive and complex networks following 
differentiation. Neuron morphology is the basis of neurological function. Neural 
progenitor and stem cells ability to proliferate and differentiate into functional progeny 
in a spatiotemporal manner are tightly regulated by several transcriptional and post 
transcriptional mechanisms (Lee et al., 2000, Ohkubo et al., 2002, Cho et al., 2013, 
Girdler et al., 2013). In the developing cortex, progenitor cells in the ventricular zone 
exits the cell cycle and start to differentiate and migrate into the sub-ventricular zone, 
intermediate zone and cortical layer (Polleux et al., 2002, Ang et al., 2003, Hack et al., 
2007, Hashimoto-Torii et al., 2008, Huang, 2009). During nervous system development, 
complex mechanisms determines the fate of the neuron, these involve interactions both 
transcriptionally and post-transcriptionally to determining final cell fate and functional 
refinement. 
 
Post transcriptional gene regulation and RNA stability 
Post-transcriptional mechanisms are responsible for regulation of growth and 
development. Post-transcriptional regulation incorporates all mechanisms involved in 
RNA processing from transcription to post transcriptional processing and translation. 
Post-transcriptional gene regulation has emerged as a key player in organizing the 
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complex relationship between genes, proteins and the cellular environment.  One of the 
most critical post-transcriptional mechanisms controlling the expression of a large 
number of genes responsible for diverse processes is RNA stability. Two major 
regulators of RNA stability are the RNA binding proteins  (RBP) and the non-coding 
RNAs, of which microRNAs (miRNAs) are the best characterized. 
RNA binding proteins are involved in RNA stability, stem cell maintenance and 
differentiation and development.  Neuronal RNA binding proteins such as HuB, HuC 
and HuD modulates the translation of developmental regulators involved in neural 
growth and development. Post-transcriptional regulation is dependent on the activity of 
RNA binding proteins acting as trans acting factors for mRNA transcripts (Pascale et al., 
2008). miRNAs regulate translation by binding to sites in the 3' untranslated region 
(3'UTR) of their target genes and also act in conjunction with sequence specific RNA 
binding proteins. The interplay between non-coding RNAs and RNA binding proteins on 
target RNAs can modulate target expression depending on the requirement of the cell. In 
principle the stability, translation efficiency and final gene outcome following 
transcription is dependent on the interaction between the mRNA transcript and its 
regulatory binding partners. 
 
RNA binding proteins  
RNA binding proteins post-transcriptionally controls the expression of a large 
number of genes responsible for diverse processes regulating neural organization. In the 
cell, RNAs do not exist as stand alone molecules, instead they are stably assembled as 
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part of ribonucleoprotein complexes (RNPs) (Kim et al., 2009). RNA binding proteins 
(RBPs) are proteins that bind RNA and regulate the outcome of all gene expression 
mechanisms (Sakakibara and Okano, 1997, Maris et al., 2005, Clery et al., 2008). RBPs 
are involved in RNA stability, in which assembly of RBPs on target RNAs results in 
either a repressive or enhancement effect. RNA binding activity can rapidly modulate 
gene expression in response to changing environmental conditions (Miller and Olivas, 
2011). RNA binding proteins are also involved in RNA splicing, RNA decay, subcellular 
localization and translation (Kim et al., 2009). RNA binding proteins recognize and bind 
to target mRNAs in a sequence dependent manner to cis-elements usually confined to 
the 3’-UTR of mRNAs, but can also be in non-coding sequences and in the 5’UTR. 
(Pascale et al., 2008). These cis-elements associate with the RBPs in specific domains 
called RNA Recognition motifs. 
 
RNA recognition motifs of the RNA binding protein 
RNA binding proteins bind to regions of their target mRNAs at specific loci 
within the protein known as the RNA-recognition motif (RRM), the RNA Binding 
Domain (RBD) or Ribonucleoprotein domain (RNP domain). The RRM is found in all 
life forms (Maris et al., 2005).  It is one of the most abundant RNA binding domains in 
higher vertebrates (Maris et al., 2005, Clery et al., 2008). An RRM consist of 
approximately 90 amino acids arranged in a β1α1β2β3α2β4 topology that forms four-
stranded β-sheets packed against two α-helices (Maris et al., 2005). It is the involvement 
of the b-hairpin that has been strongly suggested to be heavily involved in RNA binding. 
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Structural studies show that amino acids of the b-hairpin are directly hydrogen-bonded 
to bases of nucleic acid targets (Clery et al., 2008). However, the loops connecting the b 
sheets and the a helices are also crucial for nucleic acid recognition. RRMs bind a 
variable number of nucleotides ranging from a minimum of two to a maximum of eight 
for some mRNAs. Typically most RRMs has three aromatic side chains located in the β3 
and the b1-strand (Clery et al., 2008) that interacts with the bases such that the 5' and the 
3' nucleotides stack on the aromatic ring located in b1 and in b3 positions (Clery et al., 
2008). Note that the same RRMs will also interact with other proteins and not only 
RNAs. It is the conformation and hydrogen-bonding pattern for each RNA base that 
allows the RBPs to make specific interactions through a very small number of contact 
points (Morozova et al., 2006) 
 
ELAVL/Hu proteins and their targets 
ELAV/Hu proteins are homologs of Drosophila's Embryonic Lethal Abnormal 
Vision ELAV (ELAVs). They were first identified in drosophila as part of a gene 
mutation that gives rise to an embryonic lethal phenotype with numerous structural 
defects and hypotrophy of the CNS (Campos et al., 1987, Robinow et al., 1988, Yao and 
White, 1994). In humans ELAV proteins were initially identified as autoimmune 
antigens in paraneoplastic neurological disorders (Szabo et al., 1991, Ross et al., 1997, 
King et al., 1994), hence the later name Hu proteins. Hu proteins consist of four 
mammalian homologs, HuB, HuC, HuD and HuR. HuB, HuC and HuD are expressed in 
neurons and are also collectively termed neuronal ELAVs (nELAVs), whereas HuR is 
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ubiquitously expressed (Kasashima et al., 1999, Hinman and Lou, 2008). Hu proteins are 
necessary for neural development (Bolognani et al., 2010, Bolognani et al., 2006) and 
are characterized as mRNA stabilizing factors playing a significant role in promoting 
differentiation of neural progenitors (Mobarak et al., 2000, Anderson et al., 2001, 
Bolognani et al., 2010). Hu proteins have been identified as an early marker for 
commitment to the neuronal lineage (Kim et al., 1996, Wakamatsu and Weston, 1997) 
Hu proteins have three RNA recognition motifs RRMs that are highly conserved. Two 
RRMs are aligned near the N-terminus separated from the third at the C-terminus by a 
hinge region of 54-80 amino acids (Yannoni and White, 1999). In Hu proteins it has 
been shown that the N-terminus RRMs interact with the ARE whereas the C-terminus 
RRM interacts with the poly-A tail of the mature transcript (Ma et al., 1997). 
The four vertebrate Hu proteins are characterized by a high degree of sequence 
homology (70-91%) even across species (Okano and Darnell, 1997, Yannoni and White, 
1999, Samson, 2008). They are 40kDa in size and contain three approximately 90 amino 
acid-long RRM domains (Samson, 2008). The hinge regions contain the cis elements 
responsible for Hu nucleocytoplasmic shuttling. Hu proteins are distributed in both 
nuclear and cytoplasmic region of the cell (Pascale et al., 2008). Hu proteins function by 
binding to adenine uridine rich elements (AREs) in the 3'UTR of their target mRNA and 
transports them to the cytoplasm for translation (Mansfield and Keene, 2012). 
Hu proteins targets and increase transcript stability of several mRNAs that are 
involved in development. Some mRNA targets of Hu proteins include Musashi (MSI), 
GAP-43 and Id mRNAs. Musashi is a well characterized, evolutionarily conserved RNA 
  11 
binding protein (Pascale et al., 2008), that function as a regulator of mRNAs that play 
critical roles in stem cell maintenance and self-renewal (Nakamura et al., 1994, Kaneko 
et al., 2000, Okano et al., 2005). Msi is highly expressed in the developing nervous 
system precursor cells that generate both neurons and glia during embryonic and 
postnatal development (Ohyama et al., 2012). Gap-43 is neuron specific and growth 
cone localized, is essential for neuritogenesis and also functions in refining neural 
connections (Sakakibara et al., 1996, Sakakibara and Okano, 1997, Good et al., 1998, 
Sakakibara et al., 2001, Okano et al., 2005). GAP-43 is expressed very early in 
developing neurons and is a target of HuD (Sanna et al., 2014, Beckel-Mitchener et al., 
2002). Inhibitor of DNA binding (ID) proteins are helix loop helix proteins that lack the 
basic amino acid domain (Perrone-Bizzozero et al., 2011), they interact with basic helix-
loop-helix bHLH transcription factors forming a protein interaction that sequesters the 
bHLH proteins and ultimately inhibit transcription by preventing them from binding to 
DNA (Andres-Barquin et al., 2000). 
 
MicroRNAs 
MicroRNAs (miRNAs) are short non-protein coding RNAs that regulate gene 
expression through translation repression of their target mRNAs (Tzeng and de Vellis, 
1998, Lyden et al., 1999). MicroRNAs are approximately 18-25 nucleotides in length, 
small non-protein coding RNAs involved in regulating diverse cellular mechanisms 
through sequence specific binding to target RNAs (Djuranovic et al., 2012, Sano et al., 
2012, Bukhari et al., 2012). MicroRNAs are classified as either intergenic or intragenic 
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depending on the genomic location (Pillai et al., 2004, Yoo et al., 2011, Treiber et al., 
2012). Intergenic miRNAs are synthesized from their own promoters, whereas intragenic 
miRNAs are synthesized along with the host's genes, using the hosts transcriptional start 
sites (Ballarino et al., 2009, Hinske et al., 2010). MiRNAs are generated from double 
stranded precursors and interacts with members of the Argonaute (AGO) protein family 
to form the miRNA-induced silencing complex (miRISC) also referred to as the micro-
ribonucleoprotein complex (miRNP) (Gu et al., 2006, Xu et al., 2010, He et al., 2012). 
MiRNAs regulate gene expression by binding to sites in the 3' untranslated region  (3' 
UTR) of their target genes and also act in conjunction with sequence specific RNA 
binding proteins. MiRNA translation repression occurs if the regulatory site on the target 
mRNA is partially complementary to the miRNA (Lee et al., 2004, Treiber et al., 2012). 
Nucleotides 2-8 of the miRNA is known as the seed region and is essential for the 
miRNA to interact with the target mRNA (Treiber et al., 2012). AGO is fundamental in 
the translation repression by miRNAs, and is the protein that is in closest association 
with the paired miRNA-mRNA interactions, other proteins are associated more 
peripherally. The AGO family of proteins can be therefore seen as specialized small 
RNA binding proteins (Lewis et al., 2005, Zorc et al., 2012). miRNAs regulate diverse 
cellular mechanisms during translation by being an adapter that guides the miRISC, 
through interaction with AGO to the sequence specific mRNA (Ender and Meister, 
2010, Wei et al., 2012b). Some microRNAs target the actual translation initiation 
machinery by directly repressing some eukaryotic translation initiation factor (eIF) 
mRNAs, as an example Yoo et al., 2011 showed that hsa-miR-5787 targets and 
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suppresses eIF5 (Yoo et al., 2011). MiRNAs regulate neuron development, neural 
survival, maturation and plasticity. MiR-9 is highly expressed in the brain and is 
involved in neural stem cell differentiation (Coolen et al., 2012, Sun et al., 2013).  In 
neural maturation, miR-124a is required for axonal development of hippocampal 
neurons (Zhao et al., 2009). Double mutant mouse for MiR-9-2 and miR-9-3 show 
reduced numbers of Cajal-Retzius and early born neurons plus aberrant misrouting of 
thalamocortical and corticofugal axons (Sanuki et al., 2011). 
 
Long non-coding RNAs 
Long non-coding RNAs (lncRNAs) consist of a minimum of 200 nucleotides 
(Wei et al., 2013, Garitano-Trojaola et al., 2013, Wang et al., 2014). A numerous amount 
of lncRNAs are identified in the vertebrate genome (Kapranov et al., 2007).  Like 
miRNAs they are transcribed from intergenic and intragenic regions of the transcript (Li 
et al., 2012, Pauli et al., 2012). lncRNAs partially base pairs with their target mRNAs in 
a similar fashion as miRNAs. Long non-coding RNAs expression is developmentally 
regulated and associated with neural stem cell differentiation (Clark et al., 2012). Long 
non-coding RNAs are localized to specific subcellular compartments (Mercer et al., 
2008) and affect a large amount of biological processes (Clemson et al., 2009). Long 
noncoding RNAs such as HOTAIR plays a role in cancer invasion and metastasis (Bian 
and Sun, 2011), XIST is expressed only from the inactive X-chromosome thus important 
in regulating development (Geng et al., 2011) and SOX2OT (sox2 overlapping 
transcript) SOX2OT is a stable transcript that is upregulated during mesoderm-lineage 
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differentiation (Brown et al., 1991). lncRNAs can act as a repository for generating 
endogenous siRNAs that trigger degradation of targets (Amaral et al., 2009). LncRNAs 
are emerging as having key roles in translation regulation of gene networks. 
 
Eukaryotic translation 
Translation is the process by which the sequence of nucleotides in an mRNA 
molecule directs the incorporation of amino acids into proteins within the ribosome 
(Kapranov et al., 2007). Although the final product of some genes is an RNA molecule 
itself most RNA molecules serve as intermediaries in the protein synthesis pathway 
(Alberts, 2002). Translation is a multistep process involving several molecular factors. 
Translation is usually thought of as occurring in a linear fashion, from activation-
initiation-elongation- termination, however translation is in fact a cyclical process in that 
each round of translation is preceded by a previous termination event except in cases 
where there are newly assembled 40S subunits (Alberts, 2002). Translation initiation is 
the most complex component in this multi step process and as such most regulatory 
events takes place at the initiation step. Eukaryotic mRNAs has a 5'-cap and a 3' 
polyadenylate (PolyA) tail that are both required for efficient translation (Jackson et al., 
2012). 
Amino acid activation is the first step in the translation process (Imataka et al., 
1998), chief factor in this step are the amino acyl tRNA synthetases (Novelli, 1967). 
Amino acyl tRNA synthetases, one for each tRNA, regulate activation by precisely 
pairing tRNAs with their cognate amino acids via a covalent bond (Cusack, 1997). The 
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bound tRNA is referred to as a charged tRNA (Cusack, 1997, Splan et al., 2008, Park et 
al., 2008). The aminoacylation of a tRNA with its associated amino acid by an 
aminoacyl-tRNA synthetase is crucial in determining the fidelity of protein biosynthesis 
(Splan et al., 2008). Aminoacyl-tRNA synthetases also have amino acid editing 
capabilities (Klipcan and Safro, 2004). The aminoacyl-tRNA synthetase is in fact one of 
the most important component of the translation machinery as it truly defines the final 
outcome of protein translation (Sankaranarayanan and Moras, 2001). 
Following activation the next step is translation initiation. Translation initiation is 
the rate-limiting step of protein synthesis (Cusack, 1997, Splan et al., 2008) and as such 
is the step that is most regulated. The canonical pathway of eukaryotic translation 
initiation is divided into several stages regulated by essential proteins called eukaryotic 
initiation factors (eIFs) (Nukazuka et al., 2008). Translation initiation in eukaryotes 
begins with the identification and assembly of the 43S preinitiation complex (PIC) 
(Majumdar and Maitra, 2005, Majumdar et al., 2003, Lang et al., 2002, Sangthong et al., 
2007). The 43S preinitiation complex is made up of the 40S subunit and an initiator 
methyionyl tRNA (met-tRNAimet) in association with GTP bound eukaryotic initiation 
factor 2 (eIF2) (Valasek et al., 2002, Pestova et al., 1998). Initiation factors eIF1, eIF1A, 
eIF4, eIF5 and the eIF3 complex all activates assembly of the 43S complex (Valasek et 
al., 2002). The attachment of the 43S preinitiation complex to the 5’ m7GTP cap of the 
mRNA is facilitated by the eIF4F complex which is made up of eIF4A, eIF4E, eIF4G, 
and the polyA binding protein (PABP) (Jivotovskaya et al., 2006, Majumdar and Maitra, 
2005, Lomakin et al., 2003). Next, the assembled preinitiation complex scans the mRNA 
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for the initiation codon AUG, using complementarity base pairing with the anticodon of 
the initiator tRNA at the P site of the 40S subunit (Hellen, 2009, Ramirez et al., 2002). 
The molecular mechanism of scanning and start codon selection is critical to the 
formation of the preinitiation complex (Pestova and Kolupaeva, 2002, Singh et al., 2005, 
Battiste et al., 2000, He et al., 2003); this scanning mechanism has been validated by 
several studies and was first proposed by Kozak in 1978 (Kozak, 1978, Asano et al., 
2000). Upon the first AUG recognition, the scanning is stopped and the GTPase 
activating protein eIF5 causes the irreversible hydrolysis of GTP bound eIF2 resulting in 
the formation of a stable 48S preinitiation complex (Kozak, 1978). The conventional 
rule of the scanning mechanism is that the 43S preinitiation complex (PIC) will stop 
scanning when it recognizes the initiation codon which is the first AUG triplet, located at 
a favorable site from the 5’ end (Hinnebusch, 2011, Hellen, 2009, Pisarev et al., 2006), 
there are however exceptions to the first AUG rule (Hellen, 2009). The importance of 
the formation of this PIC is to assemble a stable closed loop structure that will enhance 
the fidelity of the translation machinery. DEAD-box helicases such as Ded1 assist in the 
scanning process by melting the mRNA structure so they can pass through the 
preinitiation complex (Kozak, 1989). The 48S preinitiation complex is then joined to the 
60S subunit to form the active 80S initiation complex in a reaction catalyzed by eIF5B 
and eIF2 (Hellen, 2009).  
Following translation initiation at the first codon by the 80S ribosome, the next 
step is elongation stage where the peptide chain is increased one amino acid at a time. In 
translation elongation the tRNA bound amino acids are incorporated into the growing 
  17 
polypeptide chain according to the respective mRNA template (Dever et al., 2001, Lee et 
al., 2002, Hellen, 2009, Pestova et al., 2000). Translation elongation factors are 
responsible for the efficient polypeptide synthesis on the 80S ribosomes (Lang et al., 
2001). Two distinct elongation factors required for translation elongation are elongation 
factor 1 (eEF-1) and elongation factor 2 (eEF-2) (Yaremchuk et al., 2012), along with 
corresponding isoforms (Proud, 1994, Nilsson and Nygard, 1986). Each amino acid is 
added to the C-terminal end of the growing polypeptide by means of a cycle of three 
sequential steps: aminoacyl-tRNA binding, followed by peptide bond formation, 
followed by ribosome translocation (Saha and Chakraburtty, 1986). The mRNA 
molecule progresses codon by codon through the ribosome in the 5′-to-3′ direction until 
one of three stop codons is reached.  
The final step is termination where the completed protein is released from the 
ribosome (Greganova et al., 2011). Termination of translation occurs when a termination 
or stop codon (either UAA, UAG or UGA) enters the ribosome A-site following the last 
coding sequence (Lang et al., 2001, Stansfield et al., 1995). Termination requires two 
GTP bound Eukaryotic Releasing Factors (eRFs) eRF1 and eRF3, which are bound to 
the A-site; eRF1 is responsible for codon recognition (Lang et al., 2001, Inagaki and 
Ford Doolittle, 2000). Following entry of the stop codon GTP is hydrolyzed by eRF3, 
which results in the eRF1 triggered hydrolysis of the ester bond of the peptidyl-tRNA 
located in the P-site releasing the newly synthesized polypeptide chain (Frolova et al., 
2000).  
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Translational regulation 
Translational regulation represents an important level in gene regulatory 
networks and is important in development. Translational control is an extremely 
complex process requiring continuous integration of multiple molecular mechanisms. 
Most translational control is exerted at the level of initiation, regulated by eukaryotic 
initiation factors (eIFs). A key translation initiation factor responsible for cap-dependent 
initiation is the multiprotein eIF4F complex, which is made up of eIF4G and eIF4A. The 
eIF4F complex promotes the formation of the 48S preinitiation complex (Prevot et al., 
2003). eIF4A is a DEAD-box protein that binds to the 5'UTR of mRNA, it is a RNA-
dependent ATPase and RNA helicase (Gingras et al., 1999, Ozes et al., 2011, Rogers et 
al., 2002). eIF4G is a cap binding scaffolding protein with binding domains for both 
eIF4A, eIF4E, eIF3  and polyA binding protein (Gingras et al., 1999, Andreou and 
Klostermeier, 2014)  
 
Regulatory sequences in the 3' UTR of the mRNA 
Phylogenetic assessments among yeast and mammalian genomic sequences have 
revealed that untranslated regions (UTRs) of many mRNAs are where refinement of 
selective gene expression is carried out (Zhouravleva et al., 1995, Alkalaeva et al., 
2006). The adenylate uridylate rich element (ARE) in the 3' UTR of mRNAs is one such 
regulatory sequence that mediates translational control (Hogan et al., 2008) by RNA 
binding proteins. How important are these sequences of mRNAs directly related to 
translational control? The hallmark study that first proposed AREs as regulators, was 
  19 
carried out by Shaw and Kamen in 1986 (Shaw and Kamen, 1986). They showed that 
when nucleotide sequence from granulocyte-macrophage-colony stimulating factor 
(GM-CSF) was inserted into the 3' UTR of β-globulin mRNA it was destabilized. They 
proposed that the AU sequences were recognition signals for mRNA processing that 
degrades mRNAs for certain lymphokines, cytokines and proto-oncogenes (Shaw and 
Kamen, 1986). Subsequent studies (Prasad et al., 2008, Wang et al., 2008, Charlesworth 
et al., 2006) show that the 3’ UTR is definitely a significant regulator of gene expression 
working in conjunction with trans acting factors such as RNA binding proteins and 
noncoding RNAs. AREs are composed of variable numbers of copies of the AUUAU 
pentamer or UUAUUUAUU nonamer (Lagnado et al., 1994, Jing et al., 2005, Franks 
and Lykke-Andersen, 2007, Deshpande et al., 2009, Mayr and Bartel, 2009, Hatipoglu et 
al., 2009, Cairrao et al., 2009). AREs are categorized into three classes. Class I is based 
on the presence of one to three pentamers located in the 3’UTR in close proximity to a 
uridine rich region, Class II AREs have at least two overlapping copies of the UA 
nonomer and Class III AREs do not contain any pentamers but have U-rich regions in 
close proximity (Zhang et al., 2002) 
 
Regulatory roles of the 5'UTR 
The 5'UTR contains regulatory elements that controls translation initiation 
(Zhang et al., 2002) and possesses several binding sites for trans acting elements that 
controls translation. However, unlike the 3'UTR region with specific cis-sequences that 
confer stability/instability, the 5'UTR region has no known specific cis sequences that 
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confer any type of translational control. Instead areas of regulation in the 5'UTR has to 
do with mechanisms of translation initiation factors, the 5' cap structure and steric 
hindrances caused by stem loop secondary structures located upstream of the start codon 
(Barrett et al., 2012). There has been one potential cis-sequence regulation consensus 
sequence -GCCACCAUGG- that flanks the start codon and appears to improve 
translation initiation, mutations in this sequence seems to result in the 40S subunit 
skipping the first AUG (Kozak, 1981, Curtis et al., 1995, Kozak, 2000, Barrett et al., 
2012). During cellular stress and apoptotic conditions some mRNAs contain a cis-
regulatory element in the 5" UTR called internal ribosome entry segments IRES that 
allow for cap independent translation initiation (Kozak, 1997). Translation regulation at 
the 5' UTR is most significantly determined by factors that influence translation 
initiation factors. The flow of information from the transcriptome to the proteome 
involves several regulatory factors such as RNA binding proteins and non-coding RNAs. 
Below is a representative schematic of interactions involved in post-transcriptional 
regulation involved in transcript stability and translation processing (Figure 1).  
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Figure 1. Model of transcript processing. RNA binding proteins and miRNAs 
interacting with the 3'UTR and translation initiation factors for post-transcriptional 
regulation. 
 
 
Hypothesis 
Neural stem cells exposed to alcohol prior to neuritogenesis results in 
morphological and neurocognitive deficits. Several studies have proposed mechanisms 
that may be targeted by alcohol during development, however the underlying cause of 
fetal alcohol spectrum disorders is not thoroughly understood. We hypothesize that 
alcohol exposure disrupts neuronal morphology by disrupting the functional dynamics of 
the Hu family of RNA binding proteins. 
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CHAPTER II 
ETHANOL EXPOSURE DISRUPTS STEM CELL MATURATION BY 
CHANGING THE DYNAMICS OF HU PROTEINS 
 
 
Overview 
Fetal alcohol exposure results in a cluster of birth defects termed Fetal Alcohol 
Spectrum Disorders (FASD). We have identified a family of RNA binding proteins, 
nELAVs/Hu proteins that regulate RNA stability and are important for neuronal stem 
cell maintenance and maturation. The mechanism by which alcohol affects neural 
development is unknown. We hypothesize that as a teratogen ethanol is disrupting the 
dynamic relationship between the Hu proteins and their targets, leading to altered 
progression of fetal stem cell maturation. Our data showed that ethanol affects neuron 
morphology and Hu proteins exhibits varying sensitivity to ethanol exposure. This data 
provides further information for elucidating the mechanisms by which ethanol exposure 
alter stem cell stage-specific neural RNA binding proteins and disrupt stem cell 
maturation.  
 
Introduction 
Fetal exposure to varying levels of teratogens has significant implications for the 
fidelity of fetal development programs. Fetal alcohol exposure results in an array of 
neurological and physical defects called Fetal Alcohol Spectrum Disorders (FASD) 
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(Jones and Smith, 1973, Astley and Clarren, 2000). FASD encompasses craniofacial 
dysmorphologies such as smooth philtrum, neurological deficits, growth deficiencies, 
cardiac and other abnormalties (Bertrand et al., 2005, Riley and McGee, 2005). At the 
severe end of the FASD spectrum we have Fetal Alcohol Syndrome (FAS). FAS is 
defined by confirmed prenatal exposure, neurological and growth deficits and the 
characteristic craniofacial facial dysmorphologies as outlined by the Institute of 
Medicine (IOM) (Medicine, 1996, Hoyme et al., 2005). Partial Fetal Alcohol Syndrome 
(PFAS) (Moore et al., 2001), Alcohol Related Neurodevelopment Disorder (ARND) and 
Alcohol Related Birth Defects (ARBD) (Hoyme et al., 2005, May et al., 2013a) all 
describes cases where not all characteristics of FAS are present but there is presence of  
neurological deficits and underlying structural abnormalities of brain and other organ 
systems.  
Neuron positioning during embryonic brain development occurs in a spatio-
temporal manner and is regulated by several genes (Ohkubo et al., 2002, Lee et al., 2000, 
Cho et al., 2013, Girdler et al., 2013). In the developing cortex, progenitor cells in the 
ventricular zone exits the cell cycle and differentiate and migrate into the sub-ventricular 
zone, intermediate zone and cortical layer (Polleux et al., 2002, Ang et al., 2003, Hack et 
al., 2007, Huang, 2009, Hashimoto-Torii et al., 2008). Developmental timing of 
exposure has been implicated as a determining factor in the severity of FAS (Coulter et 
al., 1993). It is believed that a higher incidence of fetal alcohol exposure tends to occur 
within the first trimester when it is believed that most pregnant women are unaware of 
their pregnancy status or they abstained from alcohol use later during the pregnancy 
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(O'Leary et al., 2010). Proliferation and maturation of neural stem cells occur between 
the end of first trimester and start of second trimester period. Fetal exposure to alcohol at 
this critical development period leads to brain dysmorphology and neurological deficits 
(Riley and McGee, 2005, Ervalahti et al., 2007, Roussotte et al., 2012). Specifically it 
has been shown that alcohol exposure leads to microcephaly and gray matter volume 
reductions (Riley et al., 2004, Nardelli et al., 2011). In addition to timing of exposure, 
concentration of alcohol per exposure is also important. Alcohol readily crosses the 
placenta and as such it has been shown that fetal amniotic fluid concentration equals that 
of the maternal blood within two hours post consumption (Nava-Ocampo et al., 2004) 
and is also slower to be metabolized from the amniotic fluid (Nava-Ocampo et al., 
2004).  
We know that ethanol does not kill neural stem cells but affects different 
subpopulations of stem cells (Santillano et al., 2005, Tingling et al., 2013) causing 
craniofacial dysmorphologies and neurological disorders. Because of this it is theorized 
that ethanol is exerting its effect by disrupting gene regulatory mechanisms. 
Development is controlled by differential gene regulation. Post-transcriptional gene 
regulation is critical for development as it is where refinement of final gene outcome 
occurs. RNA binding proteins are a major class of post- transcriptional regulators. RNA 
binding proteins bind to transcripts and regulate stability translocation, polyadenylation, 
splicing and translation. RNA binding proteins are involved in stem cell maintenance, 
differentiation and regulate all gene expression mechanisms (Sakakibara and Okano, 
1997, Maris et al., 2005, Clery et al., 2008). RNA binding proteins are particularly 
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relevant in the nervous system as their activity can rapidly modulate gene expression in 
response to changing conditions (Miller and Olivas, 2011). The Hu family of RNA 
binding proteins, homologs of Drosophila's ELAVs, were identified as important for 
neuronal stem cell development (Wakamatsu and Weston, 1997, Kasashima et al., 1999, 
Mobarak et al., 2000, Anderson et al., 2001, Bolognani et al., 2006, Perrone-Bizzozero 
et al., 2011). Hu proteins consist of four mammalian homologs, HuB, HuC, HuD and 
HuR. HuB, HuC and HuD are restricted to neurons whereas HuR is ubiquitously 
expressed. Target mRNAs that Hu proteins bind include genes for neural stem cell 
maintenance and axon guidance. RNA binding proteins containing RRMs such as Hu 
proteins interact with their mRNA targets by binding to sequences in the 3'UTR.  
The molecular mechanism of ethanol exposure that renders the developing brain 
vulnerable remains unknown. To understand ethanol's effect on neural stem cell 
developmental programs involving Hu proteins, we utilize an in vitro model of the early 
stages of neuronal maturation using mouse embryonic derived neural progenitor cells 
along with moderate to heavy ethanol exposure paradigms.  
RNA binding proteins are pleiotropic factors that act as nodes modulating several 
genes specifically related to neuronal maturation. Ethanol's effect on Hu family of RNA 
binding proteins will have a cascading effect on multiple genes responsible for neuronal 
differentiation and organizational patterns. Defects in neuronal differentiation and 
organizational patterning leads to several craniofacial abnormalities and mental deficits 
comparable to those observed in FASD. Evidence has shown that ethanol exposure 
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promotes aberrant and premature maturation and affects differentiation in neural stem 
cell populations (Santillano et al., 2005, Prock and Miranda, 2007).  
We found that ethanol influences the number of neural stem and maturing cells 
transcriptional activity and therefore hypothesized that as a teratogen, ethanol disrupts 
stem cell maturation by changing the functional dynamics of nELAV/Hu proteins. 
 
Methods 
 
Ethics statement 
Timed-pregnant C57Bl/6 mice (Harlan, Texas) were housed in an AAALAC-
approved facility at TAMHSC. All protocols were conducted with the approval of the 
Institutional Animal Care and Use Committee at TAMHSC (Approval number 
AUP2010-197). 
 
Neural precursor cultures 
Neural precursor cells were obtained from the dorsal telencephalic vesicles of 
gestational day 12.5 C57BL/6 fetal mouse based on methods by Santillano et al., 2005 
(Santillano et al., 2005). Isolated precursor cells were maintained as neurospheres in 
serum free mitogenic media, containing Dulbecco’s Minimal Essential Medium 
DMEM/F12 Lifetechnologies cat. no. 23017-015), 20 ng/ml Basic Fibroblast Growth 
Factor bFGF (BD Biosciences cat. no. 354060), 20ng/ml human Epidermal Growth 
factor hEGF (PreproTech cat. no. 100-15), 0.15 ng/ml leukemia inhibitory factor LIF 
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(Alomone labs cat. no. L-200), Insulin-transferrin selenium-X ITS-X (Lifetechnologies 
cat. no. 51500-056), 5ug/ml Heparin (Sigma-Aldrich cat. no. H4784), 50uM 
Progesterone (Sigma-Aldrich: cat. no. P7556) and Penicillin/Streptomycin (Life 
technologies cat no. 15140-122).  
 
In-vitro differentiation 
To study the effects of ethanol exposure on early stem cell maturation, we 
utilized an experimental model according to protocol by (Camarillo et al., 2007). 
Neurosphere cultures containing approximately 2 x 106 cells were assigned as either 
control or ethanol treated group with doses of 120mg/dl (26mM) ethanol or 320mg/dl 
(70mM) ethanol (Sigma Aldrich cat no., E7148) for a total of 5 days with refreshment of 
media on day 3.  For stem cell maturation, cells were later transferred to either of two 
ethanol-free mitogen withdrawal differentiation media (Camarillo et al., 2007). For 
differentiation flasks were prepared by coating with 1mg/ml laminin (Life technologies 
cat no. 23017015) for two hours at room temperature prior to use. Immediately before 
use excess laminin was carefully removed, without disturbing the coating and the flask 
gently washed once with 1X PBS solution. Cells were prepared for differentiation by 
centrifuging at 1000 rpm for 5 minutes to remove ethanol containing mitogenic media. 
Cells were then resuspended in either a partial mitogenic media containing DMEM/F12, 
5ug/ml Heparin, 1ml 100X ITS-x, 50uM progesterone, 1ml Penicillin/Streptomycin and 
2mg/ml bFGF to model an early period of differentiation or to a mitogen free media 
containing DMEM/F12, 5mg/ml Heparin, 100X ITS-x, 50µM progesterone and 
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Penicillin/Streptomycin) modeling a later period of neural differentiation. The 
resuspended cells were then transferred to the freshly prepared laminin coated culture 
flasks and incubated for 72 hours in 5% CO2 at 37°C. Cells plated in the early 
differentiation model are called Early Differentiated cells (EDCs) and cells plated in the 
later differentiation model are called (LDCs). Non-differentiated cells are called Neural 
Stem Cells (NSCs).  
 
Flow Cytometry  
To detect changes in RNA levels resulting from ethanol exposure, 5-Ethynyl 
Uridine (EU), incorporation was measured using CLICK-IT® RNA assay protocol (Life 
technologies cat no. C10329) and standard flow cytometric methods. Briefly, cells were 
incubated for two hours in media containing 5-Ethynyl Uridine on final day of culture, 
as outlined in manufacturers protocol. Non-adherent, cells were collected and 
centrifuged at 1500 rpm for 5 minutes at 4°C, washed once with ice cold PBS and 
immediately fixed using ice-cold methanol. For adherent cells, media was carefully 
removed and replaced with ice-cold methanol; a cell-scraping tool was used to gently 
remove the cells, which were then centrifuged at 1500 rpm for 5 minutes at 4°C. 
Following fixation, manufacturers protocol was employed followed by flow cytometric 
analysis. Population subtypes, debris and dead cells were gated using forward and side 
scatter profiles. Statistical analysis of flow cytometric data was done from triplicates of 
10,000 events each. 
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Immunofluorescence analysis   
Indirect immunofluorescence was carried out on cells grown on glass coverslips 
for 72 hours following ethanol treatment. Cells were incubated overnight with primary 
antibodies against a combined HuB/D, MAP-2, and Musashi-1. Following incubation, 
antigenic sites were localized with goat anti-rabbit or anti-mouse FITC or TRITC 
conjugated secondary antibodies. Nucleus was counterstained with DAPI. Images were 
captured on Nikon AR Confocal Microscope (Nikon Instruments Inc.) 
Immunofluorescence analysis was carried out on both neural stem cells and 
differentiated neurons to determine subcellular localization of the HuB/D, Musashi and 
MAP2. Differentiated neurons were grown on glass coverslips (VWR cat. No. 72196-
25) in 6-well plates (Fisher Scientific cat no. 353047) for 72hrs following treatment. 
Immunofluorescence analysis using antibodies against MAP2 (EMD Millipore cat no. 
AB5622) Elavl2 (HuB)+Elavl4 (HuD) (Abcam cat no. ab72603) and Musashi-1 (EMD 
Millipore cat no. 04-1041)). Non-differentiated cells were subjected to the same staining 
protocol as differentiated cells. 
 
Western blot analysis and cell fractionation: whole cell and nuclear and cytoplasmic 
components 
Total proteins were extracted from neural stem cells and differentiated cells using 
cell extraction buffer containing 50mM Tris pH 7.4 (Life Technologies cat. no.15504-
020), 150mM NaCl (Sigma-Aldrich cat. no. S-3014), 10% Glycerol (Fisher Scientific 
cat. no. BP229-1), 1mM EGTA (Fisher Scientific cat. No. 02783-100), 1mM Na-
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Orthovanadate, pH 10 (Sigma-Aldrich cat. no. S-6508), 5µM ZnCl2 (Sigma-Aldrich cat. 
No. Z-48750), 100mM NaF (Sigma-Aldrich cat. No. S-7920), 10ug/ml Aprotonin 
(Sigma-Aldrich cat. No. A-1153) 1ug/ml Leupeptin (Sigma-Aldrich cat. No. L-9783), 
1%Triton X-100 (Fisher scientific cat.no. BP151-100) and distilled water. On day of use 
of extraction buffer 1mM Phenylmethylsulfonylfluoride was added to buffer. Samples 
were centrifuged at 15000-18000 rpm for 10 minutes; the soluble protein in the extract 
the supernatant was collected and quantified using the Pierce BCA protein Assay Kit; 
cat no. 232225 followed by spectrophotometric measurements on TECAN plate reader 
or NanoDrop 2000 spectrophotometer.  
To obtain the subcellular distribution of Hu and Musashi, proteins were extracted 
from separate nuclear and cytoplasmic fractions according to manufactures protocol 
using the NE-PER Nuclear and Cytoplasmic extraction kit (Thermo Scientific cat. No 
78833). Samples containing 15ug of protein was mixed with a 5X loading dye,( 6.25 ml 
TRIS-HCl pH 6.8, Glycerol, β-mercaptoethanol, SDS, Bromophenol blue) and heated at 
95 °C for 7-8 minutes and then resolved using the NuPage Novex 4-12% Bis Tris 
Minigels (Life Technologies cat. no NP0336BOX) in a 1X NuPAGE® MOPS running 
buffer. Proteins were transferred to polyvinylidene (PVDF) membranes using the Life 
technologies iBlot® system. The membranes were washed 3 times in 1X TTBS (TBS-
Tween) and blocked for 1 Hr. with 5% non-fat dry milk in 1X TTBS at room 
temperature. Membranes were each incubated with primary antibodies against  HuB 
(dilution 1:200) (Sigma-Aldrich cat.no. H1538), HuC (dilution 1:300) (Abcam cat. no. 
Ab78027), HuD (dilution 1:500) (Abcam cat no. ab72603), Elavl2 (HuB)+Elavl4 (HuD) 
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(Abcam cat no. ab72603) and Musashi (1:200) (EMD Millipore cat. no. 04-1041), 
overnight at 4°C. Following incubation membranes were washed 3 times in 1X TTBS 
and incubated with horseradish peroxidase conjugated with (appropriate secondary 
antibodies) with goat anti-mouse IgG (BD Pharmingen 554002) or goat anti-rabbit IgG 
(Santa Cruz Sc-2004) dilution 1:2000 at room temperature for 1Hr. Bands were detected 
with ECL Western Lightening Western Blot Detection System (Pierce cat. no. 32109).  
Blots were imaged on the FluorChemQ® imaging equipment and quantified using the 
alphaView® analysis software. The optical density of each band was corrected by α-
tubulin or Anti-Histone core antibody (Abcam cat. no ab7832). 
 
Real time qPCR   
For mRNA expression analysis, total mRNA was isolated using mirVana RNA 
isolation kit (Life technologies cat. no. AM1561) total RNA extraction protocol, mRNA 
was quantified on the NanoDrop 2000 spectrophotometer (Thermo Scientific) and then 
reverse transcribed into cDNA using qScriptTM cDNA Supermix (Quanta Biosciences 
cat. no. 95048). Primers to HuB, HuC, HUD, Musashi and GAP43 were designed using 
NCBI PrimerBlast and USCSC Genome BLAT browsers. (List of forward and reverse 
primers: Table 1). Real Time qPCR was carried out using the Applied Biosystems 
7900HT Fast Real-Time PCR System and Quanta Biosciences Perfecta SYBR Green 
Supermix (Quanta Biosciences cat. no. 95073-012).  
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Table 1. List of mRNA primer sequences. 
 
Gene Forward primer Reverse primer 
HuB 5'-ACACAGCCAATGGTCCAACC -3' 5'- GGTGAGGAGCAGTTGTTGTTTA-3' 
HuC 5'- AATCCTGCAAGTTGGTTCGGG-3' 5'-GAGTAGTTCACAAACCCATAGCC-3' 
HuD 5'-GCCTCAGGTGTCAAATGGACC-3' 5'-CCATACCCTAAACTCTGTCCTGT -3' 
Musashi-1 5'- GCTACTGCCTGTCCCTCAAC-3' 5'- GGGTAGGGCAACTGGCTAAT-3' 
Gap-43 5'-CATCAGCCCCGCCTTAGAG-3' 5’-CCACCAGTTCAGGGACTTCTT -3' 
18S 5'-ATGGCCGTTCTTAGTTGGTG -3' 5'-CGCTGAGCCAGTCAGTGTAG -3' 
 
 
Cell culture and transfection 
A short sequence of 19 nucleotides targeting HuB location 306 and a short 
sequence of 19 nucleotides targeting HuD location 890 was constructed into OmicsLink 
short hairpin RNA (shRNA) expression clones, cat no. MSH043651-1-CH1 (Elavl2), 
and cat no. MSH029419-3-CH1 (Elavl4), purchased from Genecopoeia, Rockville, MD, 
USA) to knockdown the expression of HuB and HuD respectively. Neural stem cells 
were cultured according to our standard protocol outlined above. 24h before transfection 
cells from either ethanol treated and control group were transferred to antibiotic free 
medium. For transfection, glass coverslips in 6-well plates were coated with 1mg/ml 
laminin for 1hr. Excess laminin was removed, wells washed with 1X PBS and warm 
antibiotic free medium added to each well. Cells were trypsinized with 0.5% Trypsin-
EDTA at 37°C for 3 min. Fresh warm medium was used to stop the enzyme reaction and 
cells were pelleted by centrifugation at 1000 RPM for 5 min. Cells were then 
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resuspended in 1ml fresh medium and 10 ml was removed for counting using Countess® 
automated cell counter (Life technologies cat. no. C10310). Remaining cells were 
pelleted and resuspended in transfection buffer of volume to make a final cell 
concentration of 1.5-2.5 million cells /10 ml per well of 6-well plate. 2.5 mg of plasmid 
per 1 million cells was added to the cells in the transfection buffer. Cells were 
transfected using the NEON® transfection system (Life technologies cat. no MPK5000) 
according to manufacturers protocol with settings at 1200V for 20 milliseconds and 2 
pulses. Following electroporation cells were then added to the prepared 6-well plates and 
incubated for 72 hrs at 37°C and 5% CO2 incubation. All vectors contained eGFP or 
mCherry fluorescent proteins to enable visualization and analysis of transfection 
efficiency. Transfection efficiency was analyzed by flow cytometric analysis. 
 
Statistical analyses 
Standard statistical analysis (ANOVA) was applied to each experimental data set. 
p < 0.05, is considered statistically significant.  
 
Results 
 
Neural stem cell development model 
We modeled the fetal neural stem cell niche using Neurosphere cultures obtained 
from the early second trimester-equivalent mouse. When cultured in defined culture 
medium containing Epidermal (EGF) and Fibroblast (FGF) growth factors as well as 
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leukemia inhibitory factor (LIF) neural cells displaying a spherical morphology after 2-3 
days called neurospheres. Cells within these cultures express a number of stem cell 
markers such as Sox 9, Sox3 and c-Kit (Tingling et al., 2013). For maintenance and 
renewal of neural stem cells. Neurosphere cultures do not express neuronal 
Neurofilament and NeuN (Camarillo et al., 2007). Cultures were then driven towards 
neuronal differentiation by withdrawal of EGF, FGF and LIF following the provision of 
extracellular matrix in the form of laminin. Two distinct phenotypes are obtained; 
namely, Early and Late differentiated cells respectively (Camarillo et al., 2007). Early 
differentiated cells (EDCs) displayed a flattened morphology with mainly bipolar 
neurons or less than 5 neuritic processes. This model (Figure 2) establishes the in-vitro 
equivalent of early maturing neurons migrating to the sub-ventricular zone during 
development.  Late differentiation cells (LDCs) exhibit a flattened morphology with 
star-like neuritic processes. LDCs express NeuN and Neurofilament but not Nestin 
signifying a later maturation state (Camarillo et al., 2007). This model allows us to 
measure the immediate and persistent effects of ethanol as a teratogen affecting neuronal 
development. Neural stem cells are exposed to ethanol and the immediate effect is 
evaluated. Following ethanol withdrawal cells were allowed to differentiate to later 
maturation states and the persistent effect is evaluated.  
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Figure 2. Schematic and representative images of neural stem cell developmental 
model. 
 
 
Cell morphology and differentiation 
Because nELAVs are important regulatory RNA binding proteins for neuronal 
maturation and differentiation and because neuronal morphology is very specific we 
wanted to examine if ethanol exposure affects differentiation and morphology. Cell size 
is functionally significant in neurons and is very important for synaptic function and 
neurotransmitter release. In addition dendritic morphology is also very important for 
neural communication especially for polarized cells that transmit information along long 
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distances. Morphological features such as nuclear area and perimeter and cytoplasmic 
area and perimeter were assessed using confocal microscopy imaging for 
multidimensional measurements (Figure 3). We observed a significant interaction effect 
between ethanol exposure and differentiation state for cytoplasmic area F (2,94) = 6.26 
p<0.002, for nuclear area F (2,94) = 44.36 p< 2.61 E-14, for cytoplasmic perimeter F 
(2,94) = 4.62, P<0.01 and nuclear perimeter F (2,94) = 153, P<2.39E-30. Cytoplasmic 
area was significantly less in ethanol exposed cells at 320mg/dl in EDCs compared to 
controls p=1.44E-5. In LDCs cytoplasmic area was significantly reduced in both 
120mg/dl and 320mg/dl exposed cells p<0.002 and p< 1.05E-5 respectively. 
 
 
 
 
Figure 3. Representative image showing nuclear and cytoplasmic sampling. 
Immunolabelled images depict localization of Microtubule associated protein-2, 
MAP2 (green) and HuB/D (red), Nuclear area represented by DAPI (blue) 
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Figure 4. Morphological analysis of differentiating neurons following ethanol 
exposure. 
 
 
In cytoplasmic perimeter we observed an increase in cytoplasmic perimeter 
following differentiation. In EDC Ethanol exposure at 320mg/dl exposure levels caused 
a significant reduction in cytoplasmic perimeter compared to control P<3.5E-5. There 
was also a significant decrease in 320mg/dl compared to 120mg/dl P<0.001, suggesting 
a dose dependent interaction. This decrease persisted as the cells mature to LDCs where 
ethanol exposure at both 120mg/dl (p<0.01) and 320mg/dl (p<0.001) reduced 
cytoplasmic perimeter. In nuclear perimeter there was no observed difference in nuclear 
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perimeter in EDCs or following exposure. However in LDCs ethanol exposure at 
320mg/dl significantly increased nuclear perimeter P<2.9E-13 compared to control and 
also compared to exposure at 120mg/dl, (Figure 4). 
 
Ethanol exposure regulates global transcriptional activity in developing neurons 
Gene expression can be tightly controlled at the transcription level, which 
represents the first step in the flow of information from genome to the proteome (Nagore 
et al., 2013). First we investigated ethanol's effect on transcriptional activity and mRNA 
synthesis. Global mRNA synthesis was measured by incorporation of 5-ethynyl uridine 
(EU), an alkyne modified nucleoside analog into nascent mRNA. 5-EU is actively 
incorporated into nascent RNA but not DNA. As a true teratogen the consequences of 
ethanol exposure is persistent even after it is removed from the environment of the 
developing neural stem cells. To evaluate immediate and any persistent changes that 
would affect transcriptional activity and RNA synthesis following ethanol exposure, 
cells were cultured under ethanol-exposed conditions for 5 days followed by complete 
removal of ethanol. Cells were then maintained as neural stem cells or allowed to 
differentiate according to our differentiation protocol. Each culture was maintained 
under ethanol free conditions for 72h. EU incorporation was measured by flow 
cytometric analysis. Transcript levels were assessed following biosynthetic EU 
incorporation into newly synthesized RNA using flow cytometric analysis. 
Our data indicates that there is significant heterogeneity in both neural stem cells and in 
differentiated cells. Flow cytometric analysis allowed us to define 3 subpopulations of 
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cells in each maturation state, based on forward and side scatter analysis. These three 
subpopulations were designated as population 1, population 2 and population 3, (Figure 
5). We observed in population 1 that transcriptional activity significantly increases as 
neural stem cells mature from stem cells to EDCs and LDCs F(2,27) = 80.53, p<4.00E-12. 
NSCs had a higher transcriptional activity than EDCs p< 0.015 and LDCs p<0.013. 
Ethanol exposure did not alter transcriptional activity in population 1. In population 2 
there was a significant interaction between ethanol exposure and differentiation state 
F(4,27) = 3.80, p<0.014. There was increased transcriptional activity as the cells mature 
from NSCs to LDCs F(2,27) = 73.6, p<1.20E-11. Transcriptional activity in EDCs and 
LDCs were significantly less than in NSCs, p<0.002 and p<0.013 respectively. Ethanol 
exposure did not affect transcriptional activity of NSCs in population 2, however there 
was a significant increase in transcriptional activity in EDCs that were previously 
exposed to ethanol at a concentration of 120mg/dl, p<0.04. Transcriptional activity in 
EDCs exposed to 320mg/dl ethanol was not significantly altered. In LDC there was a 
similar trend as in EDC towards higher transcriptional activity following exposure at 
120mg/dl and no effect at exposure of 320mg/dl. 
In population 3 we observed a statistically significant decrease of transcriptional 
activity as cells mature form NSC to EDCs and LDCs, F(2,27) = 16.02, p<2.58E-05. As 
previously observed in subpopulations 1 and 2, there was a significant increase in 
transcriptional activity in population 3 as the cells mature. Ethanol exposure did not have 
any significant effect on transcriptional activity in the NSC or LDCs. However ethanol 
exposure at 320mg/dl reduced transcriptional activity in EDCs P<0.03.  
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Figure 5. Flow cytometric analysis of following biosynthetic EU incorporation into 
nascent RNA. (a) Representative dot plots of three distict subpopulations of cells 
identified by flow cytometric analysis. (b) Histograms of mean fluorescent intensity for 
each population. (c) Histograms of proportion transcriptionally active cells 
 
 
Here we see that transcriptional activity increases as neurons differentiate. This is 
important as molecular mechanisms that govern morphological characteristics and 
migration is switched on to allow for neurite formation. Transcription in EDCs appear to 
be more susceptible to ethanol exposure compared to NSCs and LDCs. EDCs represents 
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the transition from stemness to the early neuritogenesis and are undergoing significant 
programing that will determine later migration and functionality. Because active 
transcription levels were different for each population we next determined the proportion 
of cells that were transcriptionally active in each group and treatment conditions. Ten 
thousand cells were assessed in triplicate. 
In population 1 the proportion of transcriptionally active cells were significantly 
different between differentiation states F(2,27) = 41.98, p<5.18E-09. Number of cells 
increased following differentiation from NSCs to EDCs (p<0.004) and LDCs (p<0.009). 
In population 1 NSCs ethanol exposure at 120mg/dl (p<0.03) and 320mg/dl (p<0.04) 
decreased the number of transcriptionally active cells. Ethanol exposure did not alter the 
proportion of transcriptionally active cells in EDC and LDCs of population 1. 
Interestingly we observed that in population 2 in the EDC and LDCs at exposure 
of 120 mg/dl the proportion of cells that were transcriptionally active were significantly 
less than controls (p<0.01), even though the same group (EDCs previously exposed to 
ethanol at 120mg/dl) exhibited a higher level of EU incorporation (transcriptional 
activity) (Figure 5). This shows that exposure at 120mg/dl reduced the number of 
transcriptionally active cells compared to controls while simultaneously increasing 
transcriptional activity. That is, even though active cells were less, the level of activity 
was more. In population 3 in the EDC at ethanol exposure 120mg/dl we observed that 
the number of transcriptionally active cells were significantly more than control 
(p<3.98E-06) and 320mg/dl (p<0.004) cells. In population 3 NSCs and LDCs ethanol 
exposure had no observed significant effect on proportion of EU positive cells. 
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Ethanol exposure counters the developmental decrease of Hu transcripts 
Following our observation that transcriptional activity is affected by ethanol 
exposure, we wanted to determine specific effects on mRNA transcripts for each 
nELAV, HuB, HuC and HuD.  
 
HuB 
We observed a statistically significant interaction effect of both ethanol exposure 
and differentiation state on HuB mRNA expression F (4,24) = 6.87, P<0.002. In controls 
HuB mRNA expression is highest in NSCs with a reduction following differentiation. 
Specifically HuB transcript levels in NSCs were significantly greater that in EDMs 
p<0.03 and in LDMs p<0.02 Figure 6. Ethanol exposure immediate effect was a 
premature transcript reduction in the NSCs at 320mg/dl exposure (p<0.03). Following 
ethanol exposure and differentiation we observe a significant increase in HuB transcripts 
in LDCs at both 120mg/dl (p<0.045) and 320mg/dl (p<0.026). This shows that ethanol is 
having an opposing effect on HuB expression levels by increasing its expression in more 
mature neurons.  
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Figure 6. MRNA expression of nELAVs members in NSCs and differentiating 
neurons. (a) HuB. (b) HuC (c) HuD 
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HuC 
We observed an interaction effect between ethanol exposure and maturation state 
on HuC mRNA expression F (2,24) = 4.62, p<0.02. Under control conditions HuC 
expression remained relatively constant throughout the development period. In NSCs 
ethanol exposure at both 120mg/dl and 320mg/dl showed a trend towards decreasing 
HuC expression, this however was not significant (Figure 6). Again in EDCs, similar to 
HuB, we observed no significant effect of ethanol on HuC. Following ethanol exposure 
at 120mg/dl in LDCs there was a significant increase in HuC mRNA expression p< 0.05 
and also an observed significant increase at 320mg/dl exposure (p < 0.04).  
 
HuD 
What we observed in HuD is there was no significant effect or change in HuD 
expression based on differentiation state or ethanol exposure. Ethanol exposure at 
120mg/dl showed a trend towards an increase in HuD levels in LDCs compared to 
control but the increase was not significant (Figure 6). Normally, transcript levels of Hu 
are reduced upon differentiation, Hu family members have been shown to have highest 
expression earlier in neuron maturation because it is required for differentiation, 
however following cell fate determination Hu expression is usually down regulated. 
 
Expression of Hu protein 
Since we observed an increase in Hu transcript mRNA expression following 
ethanol exposure, the next step was to determine if ethanol exposure caused any change 
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in protein expression. First we isolated protein from whole cell lysates from each 
differentiation state and ethanol exposure conditions. We then used an antibody that 
recognizes both HuB and HuD to assess protein levels. In addition later differentiated 
cells were not used for comparison in our protein analyses because expression was 
repeatedly below detectable levels by western blot. This problem was more pronounced 
following nuclear fractionation. 
In whole lysate NSCs, we observed a significant interaction effect between 
differentiation state and ethanol exposure F (2,12) = 7.33, p< 0.008, (Figure 7). There was 
an increase in HuB/D protein levels following ethanol exposure at 320mg/dl p<0.05 in 
the NSC. Even though there were overall effects of ethanol in whole lysates we wanted 
to examine more specific details in different cellular components. This is important 
because interactions and stability in the nuclear compartment may be different than in 
the cytoplasmic compartment. In the nuclear fraction ethanol of NSCs exposure at 
120mg/dl caused a significant increase in protein levels compared to control, p<0.02. 
However in the EDC protein levels were significantly decreased compared to control in 
both 120mg/dl (p<0.004) and 320mg/dl (p< 0.003). In the cytoplasmic fraction, there 
was a trend towards decreased protein levels following maturation from NSCs to EDCs, 
p<0.02. There was a significant decrease in protein expression following ethanol 
exposure in the NSCs at 320mg/dl (p<0.03) compared to control, in EDCs there was an 
increase in protein levels following ethanol exposure at 120mg/dl  (p< 0.007) compared 
to control (Figure 7). 
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Figure 7. Ethanols effect on protein expression. (a) Protein quantification of HuB/D 
in  (a)Whole Lysates, (b) Nuclear fraction (c) Cytoplasmic fraction by western 
blotting. Densitometry values normalized for loading with β−tubulin for cytoplasmic 
fractions and TATA binding protein TTBP for nuclear fractions. 
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Transfections 
Following an observed general decrease in levels of Hu levels following ethanol 
exposure using different measurement parameters, and specifically seeing that ethanol 
exposure at 320mg/dl resulted in decreases in both nuclear and cytoplasmic areas and 
perimeter. Taken together our data suggests that ethanol is generally causing a reduction 
in Hu expression levels and that reduction may account for morphological changes, have 
implications for neurogenesis, migration and cell communication. To evaluate this idea 
we transfected by electroporation a validated shRNA against HuB and HuD and carried 
out a Sholl analysis for morphological assessments (Figure 8).  
 
HuB knockdown 
In HuB knockdown there was no significant difference in overall dendritic 
length. There was however a statistically significant decrease in dendritic complexity in 
HuB knockdown compared to control F (1, 38) = 41.77, p<1.33E-07. In the control group 
ethanol exposure at 320mg/dl increased dendritic complexity (p<3.53E-05), however 
there was no significant effect of ethanol exposure on dendritic complexity in the HuB 
knockdown group (Figure 9). 
 
HuD knockdown 
We observed a statistical significant decrease in dendritic length in HuD 
knockdown cells compared to controls F (1, 38) = 28, P<5.31E-06. Ethanol exposure had no 
effect on dendritc length in the control group, however in the HuD knockdown cells 
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ethanol exposure at 120mg/dl significantly increased dendritic length (p<0.04) (Figure 
9). 
 
 
 
Figure 8. Hu gene knockdown. (a) Vector information for HuB and HuD (b) Flow 
cytometric assessment of transfection efficiency (c) Schematic of Sholl Analysis 
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Figure 9. Sholl analysis.  (a) Quantitative analysis of dendritic length and (b) number 
of intersections (c) Representative image of fluorescence microscopy of transfected 
cells. Immunofluorescence stain shows transfected cells expressing eGFP (green) with 
GAP-43 (red) counterstain 
 
 
Dendritic complexity was significantly decreased in HuD knockdown compared 
to control F (1, 38) = 22.7, P <2.68 E-05. In addition in the control group ethanol exposure 
at both 120mg/dl (p <0.03) and 320mg/dl (p <0.01) resulted in significant increase in 
neuron complexity. In the knockdown group ethanol exposure resulted in a significant 
increase in complexity at 320mg/dl (p<0.014) compared to non-ethanol exposed 
knockdown cells. 
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Discussion 
Fetal alcohol exposure causes developmental impairments that lead to 
neurological deficits and structural abnormalities in the central nervous system (Bertrand 
et al., 2005). Identification of cellular targets of ethanol during neuronal differentiation is 
important to advance our understanding of FASD. Central nervous system neurons arise 
from the generation of post mitotic cells from the germinal and ventricular zones 
followed by initial neuritogenesis and differentiation. These cells are representative of 
asynchronous phases of the cell cycle and give rise to different populations of cells 
spatiotemporally. The underlying molecular mechanisms responsible for ethanol's 
teratogenic effects are still poorly understood because of the complexity of molecular 
mechanisms involved in nervous system development. Amongst key features identified 
in fetal alcohol exposure is the fact that ethanol exposure promotes premature 
differentiation and aberrant migration of cortical neurons in neural stem cell populations 
(Santillano et al., 2005, Prock and Miranda, 2007, Camarillo and Miranda, 2008), 
suggesting ethanol is exerting its effect on genes necessary for growth and 
differentiation. 
 
Ethanol exposure dysregulate production of nascent mRNA transcripts 
In this study neural stem cells were exposed to different concentrations of 
alcohol during the period of neurogenesis, alcohol was then completely removed and 
cells allowed to differentiate. During neural development neural stem cells exist as 
heterogeneous populations, with distinct molecular expression patterns and varying 
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phases of transformation (Tingling et al., 2013). We show here that different 
subpopulations of cells remain distinct and persisted throughout the development period. 
We found that immediately following exposure, ethanol dysregulate global transcript 
production and the effect of this initial dysregulation was different for each 
subpopulation of cells. Ethanol is known to reorganize cell programing, we did not see 
an immediate effect in our NSC population, we however see that the long-term effect 
was very substantial with overall increase in production of nascent mRNA in our EDCs 
and LDCs. A global increase in transcript production has several implications for 
neurogenesis, which occurs in a spatio-temporal manner, aberrant overexpression of 
genes that are required only transiently poses the problem of disrupting regulatory 
machinery of the developing neurons. This underlying reprogramming at the stem cell 
state that persists into final fate not only corroborate fetal ethanol exposure as being 
deleterious to developing neurons but it also shows us that there is a distinct 
subpopulation of cells that are resistant to ethanol's effects. Future research into 
identifying other unique properties of each subpopulation may provide us with options to 
mitigate FAE effects.  
 
Ethanol exposure reduces neuron size: Impact on brain growth and microcephaly 
Neuronal functionality is dependent on its morphology. The ability to form 
synapses depends on efficient neuritogenesis and differentiation into functional mature 
neurons. It is recognized that one of the major effects of fetal alcohol exposure is 
microcephaly, a reduction in brain size (Archibald et al., 2001, Lipinski et al., 2012). 
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Morphological assessment of ethanol pre-exposed neural cells showed a consistent 
reduction in cell size irrespective of the differentiation state. A brain size reduction in 
fetal alcohol exposure is a predictor of neurocognitive performance (Coles et al., 2011, 
Fryer et al., 2012) and neuronal migration and differentiation (Zhou et al., 2005). 
 
Ethanol exposure reverses the spatio-temporal decrease of Hu expression 
Because Hu genes are important for neuron differentiation we sought to find out 
if ethanol was affecting Hu expression. Our data was consistent with known data that the 
Hu gene expression is highest in early neuritogenesis and significantly reduced 
following differentiation (Mansfield and Keene, 2012) we observed this in two of the 
three Hu genes, however following ethanol pre-exposure this reduction was completely 
reversed especially in the LDCs, interestingly it is the LDC nuclear area and nuclear 
perimeter that are enlarged in ethanol pre-exposed cells. Here we see for the first time 
that an increase in morphology of a specific stage of neural development correlate with 
an increase in transcript expression of Hu. Moreover we see that an early effect of 
ethanol exposure is to reduce cell size in early differentiating migrating cells.  
 
Loss of HuB/D prevents ethanol induced morphology changes 
Hu proteins are expressed very early in neurons and is required for neural lineage 
commitment (Kim et al., 1996).  Hu proteins are also important in regulating gene 
expression during brain development (Bolognani et al., 2006) and enhancing neurite 
outgrowth (Anderson et al., 2003, Smith et al., 2004). Since we saw that ethanol was 
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reversing the spatiotemporal decrease of nELAVs transcripts and causing a modest 
reversal of protein expression and knowing the importance of Hu proteins in neuron 
growth and differentiation, we knocked down Hu with the rationale that the ablation of 
Hu would lead to a similar reduction in cell size similar to what was seen in our 
morphology study. Interestingly we discovered that when Hu was knocked down ethanol 
was no longer able to affect cell morphology. This observation suggests that that Hu was 
necessary for ethanol to affect cell morphology and is therefore a likely target of ethanol. 
Our Hu knockdown data showing reduction of dendritic processes was also consistent 
with previous studies showing that nELAVs are required for growth of dendritic 
processes and differentiation (Anderson et al., 2001). 
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CHAPTER III 
HU FAMILY OF RNA BINDING PROTEINS INTERACTOME: TARGETS AND 
BINDING PARTNERS 
 
Overview 
The maternal fetal environment is critical for the development of the embryo. 
Ethanol exposure during development lead to an array of congenital malformations and 
neurological deficits termed Fetal Alcohol Spectrum disorders. Alcohol exposure during 
critical periods of embryonic development is considered to be targeting molecular 
factors responsible for stem cell maturation, however the exact molecular mechanism 
remains unknown. RNA binding proteins have been identified as critical post-
transcriptional regulators governing neuronal development. A conserved family of RNA 
binding proteins, the neuronal ELAVs/Hu proteins play important roles in neuronal stem 
cell maturation. Developing neurons are susceptible to ethanol exposure; we 
demonstrated that this susceptibility is mediated via the Hu RNA binding protein. 
However, these proteins interact with other critical regulators of neuronal development 
such as other RNA binding proteins, other proteins, and microRNAs. We hypothesize 
that as a teratogen, ethanol is disrupting the dynamic relationship between the Hu protein 
interactome, gene targets and Hu repressors such as miRNAs leading to altered 
progression of fetal stem cell maturation.  
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Introduction 
Fetal Alcohol Exposure continues to be the predominant cause of a preventable 
cluster of birth defects collectively termed Fetal Alcohol Syndrome Disorders (FASD) 
(Bertrand et al., 2005, Jones and Smith, 1973, May et al., 2013a). With a prevalence rate 
of FASD ranging from 0.2 - 7/1000 live births in the United States (Senturias and 
Asamoah, 2014, May et al., 2009) and between 68-89.2/100 live births in a South 
African population, the highest levels of occurrence recorded so far (May et al., 2007). 
Other studies have shown similar prevalence rates to the United States in Australia 
(Mutch et al., 2014), and in Italy (May et al., 2011).  The total numbers of actual fetal 
alcohol exposure unknown. Globally FASD is proving to be a serious socioeconomic 
factor. In Canada it is estimated that the cost associated with FASD per individual is 
approximately $22,000 per annum (Stade et al., 2009). Children diagnosed with FAS in 
the United States incurred a mean annual medical cost of  $16,782 (Amendah et al., 
2011). The underlying molecular mechanism of ethanol on the developing fetal brain is 
unknown. Ethanol is believed to be disrupting biological programs regulating neural 
development. Hu proteins, neuronal homologs of drosophila's ELAV family of RNA 
binding proteins are important post-transcriptional regulators involved in neural 
development. RNA binding proteins modulate all aspects of RNA processing, from 
transcription, splicing, polyadenylation, RNA modification and translation. Hu proteins 
are mRNA stability factors that regulate genes required for both neural stem cell 
maintenance and neuritogenesis. Developing neurons are susceptible to ethanol; we 
postulate that this susceptibility is mediated via the Hu RNA binding protein. 
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Identification of Hu binding partners such as other proteins, mRNAs or miRNAs is 
important for defining temporal and spatial expression patterns of both Hu and their 
binding partners. Known mRNA targets of Hu proteins include GAP-43 and Musashi 
(MSI) (Sakakibara et al., 2001, Pascale et al., 2008, Okano et al., 2005, Nakamura et al., 
1994). We know that Hu proteins are localized both in nuclear and cytoplasmic 
compartments, its specific role in the mammalian nucleus is less understood but it is 
thought to associate with newly made transcripts as a part of its transcript stability 
mechanisms.  Hu proteins interact with 3'UTR of target transcripts and modulate 
transcript stability and translation. Hu also forms complexes with other proteins; Hu 
interacts with MSI and eukaryotic translation initiation factor 4A (eIF4A). In addition, a 
small class of non-coding RNAs called microRNAs regulates Hu expression. As we 
begin to evaluate sets of genes within interactomes and not on single gene outcomes, we 
may better understand the mechanisms by which teratogens such as alcohol alters 
neuronal development (Figure 10). 
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Figure 10. Schematic of the Hu interactome. Post transcriptional regulation and 
transcript processing of Hu and its binding partners. 
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Musashi is an RNA binding protein that is evolutionary conserved and regulates 
genes that are involved in stem cell maintenance and self-renewal (Nakamura et al., 
1994). Musashi is highly expressed in the developing nervous system (Sakakibara et al., 
1996) and is sometimes used as a marker for stemness (Kurihara et al., 1997, Good et al., 
1998, Kaneko et al., 2000). Musashi's role in stem cell maintenance is thought to occur 
by translation repression of its target genes (MacNicol et al., 2008). Musashi possesses 
RNA recognition motifs (RRMs) similar to Hu, however Musashi only has two RRMs 
whereas Hu has three RRMs (Kurihara et al., 1997). Musashi binds to the 3'UTR of its 
target mRNAs, the exact binding mechanism is unknown but it has been shown that Msi 
preferentially bind to GU rich regions in the 3'UTR (Kurihara et al., 1997). More 
recently it was shown that Musashi binds to UAG, a three nucleotide motif in the 3'UTR 
(Zearfoss et al., 2014) Hu proteins share an interesting relationship with Musashi, Hu 
proteins target and stabilize Musashi mRNA (Ratti et al., 2006) in addition Hu protein 
and Musashi protein colocalize in neural stem and progenitor cells (Ratti et al., 2006) 
suggesting protein-protein interaction. It is theorized that as a part of the post-
transcriptional regulatory interactome, both Hu and MSI RNA binding proteins act in 
conjunction to determine the spatio-temporal maturation of neural stem cells. 
Neuritogenesis is important for neuron maturation and morphology. Proteins that 
promote growth of axons and dendrites and allow for synaptogenesis regulate neuron 
morphology and are important for neural function. Growth Associated Protein, GAP-43 
is a phosphoprotein that regulates neuron growth; it is localized to the growth cones 
during neuronal development (Strittmatter et al., 1995, Beckel-Mitchener et al., 2002). 
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Because of its role in neuritogenesis and synaptogenesis, GAP-43 is important for the 
spatio-temporal organization of the brain during development and is important for neural 
circuitry. Hu has been shown to target and stabilize GAP-43 mRNA, hence its role in 
neuronal maturation.  
Because Hu RNA binding proteins are significant post-transcriptional regulators 
acting as central nodes in the interactome, factors affecting Hu expression becomes 
important determinants of developmental processes, microRNAs are one such factor that 
target Hu proteins. MicroRNAs are 18-25 nucleotide small noncoding RNAs that act as 
translation repressors by binding to sequences in the 3' UTR of target mRNA (Cullen, 
2004, Ruan et al., 2009, Sevli et al., 2010). MicroRNAs are an important class of post-
transcriptional regulators that was first identified in C. elegans, but also exist in plants, 
animals and viruses (Lee et al., 1993, Lau et al., 2001, Lu et al., 2008). MicroRNAs are 
thought to affect gene expression post transcriptionally by formation of partial 
complementarity to their target mRNA, via their seed region, which is located between 
nucleotides 2-8 and thereby inhibiting translation (Wu et al., 2006, Treiber et al., 2012). 
Following synthesis in the nucleus, microRNAs are translocated to the cytoplasm where 
they are loaded onto the RNA Induced Silencing Complex (RISC) (Long and Lahiri, 
2012). RISC is made up of the proteins Dicer and Argonaute (AGO) that are both 
necessary for post-transcriptional gene repression by microRNAs. Dicers role is to 
cleave the precursor microRNA to produce mature miRNAs (Lee et al., 2013). It is the 
action of the AGO protein that mediates the translation repression by its endonuclease 
activity (Huang and Li, 2014, Ender and Meister, 2010, Wei et al., 2012a). MicroRNAs 
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have been shown to be potent regulators of neural development (Yoo et al., 2011, Zhao 
et al., 2009, Sanuki et al., 2011). Ethanol affects the expression of several developmental 
associated mRNAs (Grummer and Zachman, 1995, Naassila and Daoust, 2002). Because 
microRNAs bind to the 3'UTR it is proposed that microRNAs work in conjunction with 
RNA binding proteins to regulate gene expression.  
Post-transcriptional gene regulation inevitably serves the purpose of either 
enhancing or repressing of translation. Translation is a highly regulated process and 
requires continuous integration of multiple molecular mechanisms. Several post-
transcriptional regulators such as Hu and MSI proteins along with microRNAs and the 
RISC complex actively partake in translational control (Pillai et al., 2004, Glorian et al., 
2011). Translation initiation is the rate-limiting step of protein synthesis (Splan et al., 
2008) and most translational control is exerted at the level of translation initiation. The 
eukaryotic initiation factor 4F (eIF4F) is a multiprotein complex responsible for cap 
dependent translation initiation at the 5'UTR. eIF4F acts as a scaffolding protein with 
binding domains for interaction with eIF4A, eIF4G and the poly A binding protein 
(Gingras et al., 1999, Andreou and Klostermeier, 2014). eIF4A is a DEAD-box protein 
that binds to the 5'UTR of mRNA, it is a RNA-dependent ATPase and RNA helicase 
(Gingras et al., 1999, Ozes et al., 2011, Rogers et al., 2002). eIF4G is a cap binding 
scaffolding protein with binding domains for both eIF4A, eIF4E, eIF3  and polyA 
binding protein (Gingras et al., 1999, Andreou and Klostermeier, 2014). Understanding 
ethanol's effect on the Hu family of RNA binding proteins and their binding partners not 
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only unravel the complexities involved in neural development, but also assist with 
designing therapeutic for FASD. 
 
Methods 
 
Ethics statement 
Timed-pregnant C57Bl/6 mice (Harlan, Texas) were housed in an AAALAC-
approved facility at TAMHSC. All protocols were conducted with the approval of the 
Institutional Animal Care and Use Committee at TAMHSC (Approval number 
AUP2010-197). 
 
Neural precursor cultures 
Neural precursor cells were obtained from the dorsal telencephalic vesicles of 
gestational day 12.5 C57BL/6 fetal mouse based on methods by Santillano et al., 2005 
(Santillano et al., 2005). Isolated precursor cells were maintained as neurospheres in 
serum free mitogenic media, containing Dulbecco’s Minimal Essential Medium 
DMEM/F12 (Lifetechnologies cat. no. 23017-015), 20 ng/ml Basic Fibroblast Growth 
Factor bFGF (BD Biosciences cat. no. 354060), 20ng/ml human Epidermal Growth 
factor hEGF (PreproTech cat. no. 100-15), 0.15 ng/ml leukemia inhibitory factor LIF 
(Alomone labs cat. no. L-200), Insulin-transferrin selenium-X ITS-X (Lifetechnologies 
cat. no. 51500-056), 5ug/ml Heparin (Sigma-Aldrich cat. no. H4784), 50uM 
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Progesterone (Sigma-Aldrich: cat. no. P7556), Penicillin/Streptomycin (Life 
technologies cat no. 15140-122).  
 
In-vitro differentiation 
To study the effects of ethanol exposure on early stem cell maturation, the 
experimental model was according to protocol by (Camarillo et al., 2007). Neurosphere 
cultures containing approximately 2 x 106 cells were assigned as either control or ethanol 
treated group with doses of 120mg/dl (26mM) ethanol or 320mg/dl (70mM) ethanol 
(Sigma Aldrich cat. no. E7148) for a total of 5 days with refreshment of media on day 3.  
For stem cell maturation, cells were later transferred to either of two ethanol-free 
mitogen withdrawal differentiation media (Camarillo et al., 2007). For differentiation 
flasks were prepared by coating with 1mg/ml laminin (Life technologies cat. no. 
23017015) for two hours at room temperature prior to use. Immediately before use 
excess laminin was carefully removed, without disturbing the coating and the flask 
gently washed once with 1X PBS solution. Cells were prepared for differentiation by 
centrifuging at 1000 rpm for 5 minutes to remove ethanol containing mitogenic media. 
Cells were then resuspended in either a partial mitogenic media containing DMEM/F12, 
5ug/ml Heparin, 1ml 100X ITS-x, 50uM progesterone, 1ml Penicillin/Streptomycin and 
2mg/ml bFGF to model an early period of differentiation or to a mitogen free media 
containing DMEM/F12, 5mg/ml Heparin, 100X ITS-x, 50µM progesterone and 
Penicillin/Streptomycin) modeling a later period of neural differentiation. The 
resuspended cells were then transferred to the freshly prepared laminin coated culture 
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flasks and incubated for 72 hours in 5% CO2 at 37°C. Cells plated in the early 
differentiation model are called Early Differentiated cells (EDCs) and cells plated in the 
later differentiation model are called (LDCs). Non-differentiated cells are called Neural 
Stem Cells (NSCs).  
 
Immunofluorescence   
Indirect immunofluorescence was carried out on cells grown on glass coverslips 
for 72 hours. Cells were incubated overnight with primary antibodies against HuB/D, 
GAP-43, and Musashi-1. Following incubation, antigenic sites were localized with goat 
anti-rabbit or anti-mouse FITC or TRITC conjugated secondary antibodies. Images were 
captured on 
 
Western blot analysis: whole cell and nuclear and cytoplasmic components 
Total proteins were extracted from neural stem cells and differentiated cells using 
cell extraction buffer containing 50mM Tris pH 7.4 (Life Technologies cat. no.15504-
020), 150mM NaCl (Sigma-Aldrich cat. no. S-3014), 10% Glycerol (Fisher Scientific 
cat. no. BP229-1), 1mM EGTA (Fisher Scientific cat. No. 02783-100), 1mM Na-
Orthovanadate, pH 10 (Sigma-Aldrich cat. no. S-6508), 5µM ZnCl2 (Sigma-Aldrich cat. 
No. Z-48750), 100mM NaF (Sigma-Aldrich cat. No. S-7920), 10ug/ml Aprotonin 
(Sigma-Aldrich cat. No. A-1153) 1ug/ml Leupeptin (Sigma-Aldrich cat. No. L-9783), 
1%Triton X-100 (Fisher scientific cat.no. BP151-100) and distilled water. On day of use 
of extraction buffer 1mM Phenylmethylsulfonylfluoride was added to buffer. Samples 
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were centrifuged at 15000-18000 rpm for 10 minutes; the soluble protein in the extract 
the supernatant was collected and quantified using the Pierce BCA protein Assay Kit; 
cat no. 232225 followed by spectrophotometric measurements on TECAN plate reader 
or NanoDrop 2000 spectrophotometer.  
To obtain the subcellular distribution of the GAP-43 and Musashi, proteins were 
extracted from separate nuclear and cytoplasmic fractions according to manufactures 
protocol using the NE-PER Nuclear and Cytoplasmic extraction kit (Thermo Scientific 
cat. No 78833). Samples containing 15ug of protein was mixed with a 5X loading dye, 
6.25 ml TRIS-HCl pH 6.8, Glycerol, β-mercaptoethanol, SDS, Bromophenol blue and 
heated at 95 °C for 7-8 minutes and then resolved using the NuPage Novex 4-12% Bis 
Tris Minigels (Life Technologies cat. no NP0336BOX) in a 1X NuPAGE® MOPS 
running buffer. Proteins were transferred to polyvinylidene (PVDF) membranes using 
the Life technologies iBlot® system. The membranes were washed 3 times in 1X TTBS 
(TBS-Tween) and blocked for 1 Hr. with 5% non-fat dry milk in 1X TTBS at room 
temperature. Membranes were each incubated with primary antibodies against Elavl2 
(dilution 1:200) (Sigma-Aldrich cat.no. H1538), HuC (dilution 1:300) (Abcam cat. no. 
Ab78027), HuD (dilution 1:500) (Sigma-Aldrich H5789) and Musashi (1:200) (EMD 
Millipore cat. no. 04-1041), overnight at 4°C. Following incubation membranes were 
washed 3 times in 1X TTBS and incubated with horseradish peroxidase conjugated with 
(appropriate secondary antibodies) with goat anti-mouse IgG (BD Pharmingen 554002) 
or goat anti-rabbit IgG (Santa Cruz Sc-2004) dilution 1:2000 at room temperature for 
1Hr. Bands were detected with ECL Western Lightening Western Blot Detection System 
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(Pierce cat. no. 32109).  Blots were imaged on the FluorChemQ® imaging equipment 
and quantified using the alphaView® analysis software. The optical density of each band 
was corrected by α-tubulin or Anti-Histone core antibody (Abcam cat. no ab7832). 
 
Real time qPCR   
For mRNA expression analysis, total mRNA was isolated using mirVana miRNA 
isolation kit (Life technologies cat. no. AM1561) total RNA extraction protocol, mRNA 
was quantified on the NanoDrop 2000 spectrophotometer (Thermo Scientific) and then 
reverse transcribed into cDNA using qScriptTM cDNA Supermix (Quanta Biosciences 
cat. no. 95048). Primers to Musashi and GAP43 were designed using NCBI PrimerBlast 
and USCSC Genome BLAT browsers. (List of forward and reverse primers: table 1). 
Real Time qPCR was carried out using the Applied Biosystems 7900HT Fast Real-Time 
PCR System and Quanta Biosciences Perfecta SYBR Green Supermix (Quanta 
Biosciences cat. no. 95073-012).  
 
Reversible crosslinking coupled with immunopreciptation followed by analysis of 
immunoprecipated RNA microarray analysis 
To identify the cellular context within which RNA binding proteins interact with 
cognate mRNAs and to identify how RNA binding proteins associate with each other as 
a component of the ribonucleoprotein complex a combination of biochemical and 
genetic approach in the form of Reversible Cross-linking followed by Ribonucleoprotein 
Immunoprecipitation, reversal of crosslinking, RT-PCR and microarray will be 
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employed. A Ribonucleoprotein Immunoprecipitation assay will be carried out 
according to protocol by Niranjanakumari, (Niranjanakumari et al., 2002) with 
optimizations suitable for our experimental paradigm. Briefly, neural progenitors are 
cultured according to our laboratory protocol outlined above and cross-linked using 
paraformaldehyde. Following crosslinking, immunoprecipitation of HuB/D and Musashi 
along with associated molecules was carried out using Dynabeads® Protein G was 
carried out following manufacturers protocol. Following immunoprecipitation, 
characterization of the immunoprecipitated components was then analyzed by 
microarray analysis. For mRNA microarray analysis, 1.0µg of purified mRNA samples 
from either HuB/D or Musashi RIP from each treatment group were combined with 50pg 
RNA spike-in control. First strand cDNA synthesis was carried out at 42°C for 2hrs 
followed by second strand cDNA synthesis at 16°C for 2hrs. Following cDNA 
purification Biotin labeled cRNA samples were synthesized by a linear amplification 
method using Ambion’s MessageAmp™ II‐Biotin Enhanced Kit (Life Technologies, cat. 
no. Am1791). 10µg of biotin labeled cRNA samples were fragmented at 94° C for 20 
minutes and then combined with hybridization buffer (Applied Microarray, Tempe AZ). 
Hybridization was done with the CodeLink™ expression bioarray (Applied Microarray, 
Tempe AZ) at 37°C for 18h. Post‐hybridization processing and secondary‐labeling with 
Alexa Fluor 647-Streptavidin was done according to the manufacturer’s instructions 
(Applied Microarrays). Microarrays were scanned using a GenePix 4000B scanner 
(Molecular Devices, Sunnyvale, CA). 
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Statistical analyses 
Standard statistical analysis (ANOVA) was applied to each experimental data set. 
p < 0.05, is considered statistically significant.  
 
Results 
 
Effect of ethanol MSI and GAP-43 transcripts and protein expression  
We previously showed that ethanol was exerting its effect on developing neural 
stem cells through Hu RNA binding proteins, we next explored if this effect would 
disrupt Hu protein relationship with its binding partners which include MSI, GAP-43 
and several presumptive microRNAs. When target transcript expression was analyzed 
we saw that the levels of MSI mRNA was affected by ethanol exposure. There was a 
significant interaction effect between differentiation state and ethanol exposure F (4,24) 
= 3.57, p<0.02. Our data indicated that MSI expression was highest in NSCs with a trend 
towards maturation dependent reduction transcript levels were highest in NSCs 
compared to EDM (p<0.03) and LDM (p<0.008). In NSCs ethanol exposure at 120mg/dl 
(p<0.04) and 320mg/dl (p<0.04) reduced MSI mRNA transcripts. In LDCs there was an 
attempt to compensate for the loss in NSCs that resulted in an increase of MSI transcript 
levels in the 120mg/dl exposed cells, this however was not significant compared to 
control (Figure 11). GAP-43 transcript levels were not altered by differentiation state or 
ethanol exposure. The cellular localization of Hu and GAP-43 and Hu and Musashi are 
shown in Figures 24-25 in Appendix.  
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Figure 11. MRNA expression of GAP43 and MSI. (a) GAP-43 and (b) MSI in 
differentiating neurons 
 
 
We next assessed if ethanol was having an effect on MSI protein levels (Figure 
12). In our cytoplasmic fraction ethanol exposure had an effect on MSI protein levels, F 
(2,12) = 4.59, p<0.03. Specifically in the EDCs ethanol exposure caused an increase in 
protein expression at exposure levels at 120mg/dl compared to controls (p<0.007). In the 
nuclear fraction ethanol exposure decreased MSI protein expression levels at 120mg/dl 
(p<0.04) and at 320mg/dl (p<0.05), compared to controls. There was no effect of ethanol 
exposure on protein expression of GAP-43 in cytoplasmic or nuclear fraction (Figure 
13).  
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Figure 12. Ethanols effect on protein expression of Hu target Musashi.  Protein 
quantification of Musashi MSI in  (a) Cytoplasmic fraction, (b) Nuclear fraction by 
western blotting. Densitometry values normalized for loading with β−tubulin for 
cytoplasmic fractions and TATA binding protein (TTBP) for nuclear fractions.. 
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Figure 13. Ethanols effect on protein expression of Hu target GAP-43.  Protein 
quantification of GAP-43 in  (a) Cytoplasmic fraction, (b) Nuclear fraction by western 
blotting. Densitometry values normalized for loading with β−tubulin for cytoplasmic 
fractions and TATA binding protein (TTBP) for nuclear fractions. 
 
 
Here we show that MSI protein is more susceptible to ethanol exposure than 
GAP-43, in addition A Pearsons correlation done to assess the relationship between Hu 
protein levels and MSI protein expression, there was a positive correlation r = 0.94, 
p<0.05. 
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Hu and MSI interact with eIF4A but not eIF4g during translation 
To further explore the role of Hu in translation enhancement, we investigated 
protein-protein interaction of Hu and MSI with two key translation initiation factors, 
eIF4A and eIF4G. Our data shows that eIF4A and Hu are binding partners but not 
eIF4G. We also showed that MSI and eIF4A interacts but MSI did not associate with 
eIF4G (Figure 14). In addition these interactions were not altered by ethanol exposure. 
Overall eIF4A protein levels were also assessed in whole lysates, ethanol exposure did 
not affect eIF4A protein levels in whole lysates (Figure 15). 
 
 
 
Figure 14. Interaction of Hu and MSI with eIF4A. Western blotting quantification of 
eIF4A expression following immunoprecipitation with (a) HuB/D and (b) Musashi. 
Densitometry values normalized for loading with ΙgG. 
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Figure 15. Protein Expression of eIF4A in whole lysates. Densitometry values 
normalized for loading with β−tubulin. 
 
 
Identification of novel nELAVs gene interactions using RNA immunoprecipitation 
(RIP) and microarray analysis  
Because of the strong correlation between HuB/D and MSI expression, we 
carried out RIP using antibodies for both Hu and MSI to identify genes targeted by each 
RNA binding protein. We hypothesized that as RNA binding proteins with opposing 
effects on differentiation and a strong correlation of between their protein expression 
levels the association may be synergistic or antagonistic in regulating the spatiotemporal 
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development of the nervous system and as such we may see a significant association of 
the same genes with both RBPs. To determine this we carried out RIP using antibodies 
for Hu and MSI followed by microarray analysis to identify associated genes. 
Furthermore RIP and microarray was done on both ethanol exposed and control NSC. 
By crosslinking prior to immunoprecipitation we ensure that the RNA-Protein 
interactions remain intact. Ontology analysis showed that several genes related to neural 
development and neurogenesis was associated with each RBP; moreover we also 
identified groups of genes commonly associated with both, (Figure 16). Cluster analysis 
with average linkage and rows centering on genes showing ethanol exposed were 
different from controls (Figure 17). Importantly we also saw that ethanol exposure 
changed these association patterns. Identifying novel binding interactions and 
identifying ethanol's disruption of these genes will not only provide information on 
ethanol exposure but also guide future studies into understanding FASD. 
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Figure 16. Comparison of gene expression following Hu and MSI RIP. (a) Heat map 
of replicates showing genes commonly unregulated and down regulated and 
differentially between in Hu and MSI pulldown (b) Boxplots of normalized samples. 
(a) 
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Figure 16 continued 
 
 
 
 
 
 
 
 
 
(b) 
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Figure 17. Microarray analysis. (a) Microarray screen of Hu and MSI bound mRNAs. 
Euclidean cluster analysis with average linkage and rows centering on genes showing 
ethanol exposed were different from controls. (b) Principal Component Analysis 
 
 
MiRNA expression and Microarray of polyA transcripts 
Targetscan prediction, (Figure 18), (Lewis et al., 2005, Grimson et al., 2007, 
Friedman et al., 2009), of miRNAs targeting nELAVs revealed three potential 
candidates for our assessment, mir-375, mir-410 and mir-4661-3p (list of primers: Table 
2). Preliminary qPCR analysis of expression of mir-375, mir-410 and mir-4661-3p in in 
both neural stem cells and early and later differentiated cell populations, showed that 
(a) (b) 
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mir-375 was most stably expressed, Figure 19. In addition, several studies have shown 
that mir-375 is involved in cell growth and proliferation (Liu et al., 2010, Xu et al., 
2014). As a result we focused the remainder of our assessment using only mir-375.  
 
 
 
 
Figure 18. Targetscan prediction of ELAVL2 (HuB) as target of miR-375.  
 
 
Table 2. List of miRNA primer sequences. 
 
 
 
 
 
Gene Forward primer Reverse primer 
miR-375 5'-ACACAGCCAATGGTCCAACC -3' 5'- GGTGAGGAGCAGTTGTTGTTTA-3' 
miR-410 5'- AATCCTGCAAGTTGGTTCGGG-3' 5'-GAGTAGTTCACAAACCCATAGCC-3' 
miR-4661 5'-GCCTCAGGTGTCAAATGGACC-3' 5'-CCATACCCTAAACTCTGTCCTGT -3' 
U6 snRNA 5’- TCCGGTGAGGTCCGTTAGG-3' 5'-CAGACTCATCGGGTCGTCC-3' 
Targetscan.org: Release 6.2 June 2012 (Lewis et al., 2005, Grimson et al., 2007, 
Friedman et al., 2009) 
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Figure 19. Mir-375 expression in neural stem cells 
 
 
We saw that there was an interaction effect of ethanol exposure and 
differentiation state on mir-375 expression F (4,43) = 4.46, (p<0.004). Ethanol exposure 
caused overexpression of mir-375 expression in NSCs at 120mg/dl exposure (p<0.003) 
and at 320mg/dl (p<0.002) and in LDCs at 120mg/dl (p<0.008). Furthermore we wanted 
to see if there are novel ethanol sensitive miRNAs. To ensure that were not evaluating 
free circulating miRNAs that would give false amplification results, we carried out a 
polyA pull-down prior to CDNA synthesis. This ensures that only miRNAs that are 
associated with mature RNAs will be assessed. Exiqon miRCURY LNA Universal RT 
miRNA PCR panels (Exiqon miRNA Ready-to-use PCR Human Panels I+II V2.M/R; 
Exiqon, Vedbaek, Denmark) of prealiquoted LNA PCR primer sets on 384 well plates 
arrays were used for high throughput miRNA expression analysis. Combined Ct values 
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for panel 1 and panel 2 were used for data analysis (Figure 20). DIANA-mirPath 
(Papadopoulos et al., 2009) analyses of relevant signaling pathways are shown in figures 
21-23.  
 
 
 
Figure 20. Identification of novel ethanol sensitive microRNAs. PolyA pull down for 
identification of miRNAs that are ethanol sensitive and are involved in growth and 
development.  
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Figure 21. Microarray analysis signaling pathway involved in axon guidance. 
DIANA-mirPath; (Papadopoulos et al., 2009). 
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Figure 22. Microarray analysis: signaling pathways involved in Neurotrophin 
signaling. DIANA-mirPath; (Papadopoulos et al., 2009). 
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Figure 23. Microarray analysis signaling pathway involved the mRNA surveillance 
pathway. DIANA-mirPath; (Papadopoulos et al., 2009) 
 
 
Discussion 
Because the relationship between RNA binding proteins and their targets are 
complex any factor that causes change regardless of the directionality will have an effect 
on the interaction. The challenge is pinpointing how these changes contribute to 
modulating downstream processes. An added complexity is that RNA binding protein 
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genes are also vulnerable targets of post-transcriptional regulators such as microRNAs 
and the dynamic interaction does influence RNA binding proteins functions. Here we 
show that of known targets of nELAVs MSI does seem to have more of an association 
with Hu in our developmental model and is also targeted by ethanol. Our data shows that 
ethanol targets MSI expression just at the interface where stemness is lost, that is at the 
neural progenitor stage triggering the assumption that there was a considerable effect on 
the stem cells that caused reprogramming to be noticed at early differentiation when MSI 
expression is less significant in maintaining stemness but become important for other 
molecular events. As we see from the array data Musashi and several other genes 
interact but there is paucity of information on these interactions and their overall role in 
neural development.  
 
Impact of Hu proteins on translation 
Translation regulation mandates the process of embryonic development and is a 
highly complex process involving several proteins chief of which are the translation 
initiation factors. Translation initiation is widely studied and is shown to be the most 
highly regulated area of translation.  It is known that Hu proteins increase stability of 
several RNAs that are specifically expressed during neural development. Hu proteins 
have been shown to both enhance and suppress translation (Galban et al., 2008, 
Kullmann et al., 2002), but are more recognized as enhancers. It is established that Hu 
proteins bind to and stabilize their target transcripts but their roles go beyond transcript 
stability. In our crosslinking and immunoprecipitation study to evaluate protein-protein 
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interactions, we saw that nELAVs specifically interacted with eIF4A but not eIF4G. 
This is consistent with previous studies showing an interaction with eIF4A but not with 
eIF4G (Fukao et al., 2009). Our data suggests that Hu the interaction between eIF4A and 
Hu is for further anchoring of the Hu protein within the transcription machinery to allow 
for prevention of other RNA binding proteins or miRNAs from interacting with and 
destabilizing the transcript. This is a conceivable concept, as the transcript has to be 
efficiently and stably incorporated into the ribonucleoprotein complex for efficient 
translation. Therefore Hu proteins are not just for translocation and delivery but are 
essential for translation.  Ethanol exposure did not affect the interaction between Hu and 
eIF4A in our experimental model. MSI also interacted with eIF4A, and because 
interestingly MSI and Hu share common transcripts this data suggests that Hu, which are 
known translation enhancers, and MSI, which is known to repress translation, are acting 
antagonistically in regulating neural development. 
 
Impact of MicroRNAs  
Because we saw that ethanol increased mir-375 we went back to our nELAVs 
protein expression data and there was no observed correlation between the expression of 
mir-375 and HuB/D protein levels. MiRNAs work by primarily inhibiting translation of 
their targets by effectively blocking the translation machinery and hence final protein. 
The expected result would have been that overexpression or decrease of mir-375 would 
lead to the opposing effect in protein levels. Conceptually we cannot conclude the lack 
of such association because we did not do a direct expression study (explain better by 
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saying which method could better answer the question). Since mir-375 expression was 
induced by ethanol exposure making it an ethanol sensitive miRNA. A uniquely relevant 
study of mir-375 effect on HuD by Abdelmohsen (Abdelmohsen et al., 2010) showed 
that overexpression of mir-375 inhibited neurite differentiation (Abdelmohsen et al., 
2010). Since we saw that ethanol exposure induced expression of mir-375, would 
knocking down mir-375 in ethanol pre-exposed cells rescue them from growth and 
differentiation inhibition seen in our morphology data?  Mir-375 inhibitor was 
introduced in-vitro according to transfection protocol. Sholl analysis data showed that 
there was a decrease in cell complexity following ethanol exposure. Interestingly for 
dendritic length we saw that ethanol exposure and non-exposed were not statistically 
different.  
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CHAPTER IV 
SUMMARY 
 
In summary we observe key neural development factors such as heterogeneous 
subcellular populations. Suggesting that cohorts of cells act as functional niches that are 
differentially targeted by ethanol.  When one carries out genome-wide studies it is 
usually assumed that variations taken collectively will explain the complexities involved 
in the interactome. Here we show that it is important to identify population cohorts as 
functional units. This is very difficult to undertake but will contribute more to our 
understanding of complex cell biology and regulation of biological processes. From our 
global transcription analyses the data identified multiple population subtypes in all three 
differentiation states, with ethanol differentially regulating transcription levels in some 
groups but not others. Our morphology data is also consistent with our findings of 
population heterogeneity where we saw very low MAP2 expression in cells taken from 
the ventricular zone. Normally MAP2 expression is seen later in development, as it is 
necessary for neuritogenesis (Huang et al., 2013). This observation we theorized, is an 
explanation for the spectrum of variations observed in FAS. It is known that 
development period of exposure explains some of the variations (Maier et al., 1999) in 
the outcome of FAS.  
Future identification of all unique factors within these subpopulations of 
developing neurons will significantly assist in development of targeted therapeutics in 
mitigating the effects of fetal alcohol exposure.    
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We also found that ethanol is specifically targeting expression levels of RNA 
binding proteins that possesses RRMs that bind to AREs. From our evaluations Hu and 
MSI were significantly affected by ethanol compared to GAP-43, eIF4A and eIF4G. 
Further structural analyses and binding site studies between Hu, Musashi and ethanol 
would shed light on how the structure of RNA binding proteins possessing RRMs that 
binds to AREs are targeted by alcohol. From our knockdown evaluation of HuB and 
HuD it is seems that ethanol's effect on neuron morphology is through a direct 
interaction with Hu.  
RNA binding proteins act as central nodes post-transcriptionally therefore factors 
that changes Hu expression during critical development time points will be deleterious 
and may account for some structural and neurological deficits seen in FAS. It has been 
shown that Hu proteins increases amount of and stability of GAP-43 which is necessary 
for neuritogenesis. We saw that even though ethanol exposure did not significantly alter 
GAP-43 expression, RIP array showed that several other genes are interacting with Hu 
and are important in neuron growth and development whose expressions are changed 
following exposure. In addition ethanol sensitivity is not necessarily dose dependent as 
we observed in several instances where exposure at 120mg/dl seemed to have a more 
significant aberration of morphology and expression levels from the control compared to 
exposure at 320mg/dl.  
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APPENDIX  
 
 
Figure 24. Representative immunofluorescence images showing cellular localization 
of Hu and GAP-43. HuB/D: red, GAP-43-green. 
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Figure 25. Representative immunofluorescence images showing expression of Hu and 
Musashi in NSC. HuB/D: red, Musashi-green 
 
